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PREFACE
 
This dissertation embodies the major projects I contributed to as a graduate student 
over the past six years in the lab of John Kim. The main focus of my research was the 
characterization of factors that regulate the microRNA-induced silencing complex 
(miRISC) using the model organism C. elegans. Fortuitously, my work was given 
breadth thought the exploration of factors with opposing roles and different modes of 
modulating microRNA (miRNA) function: Casein Kinase 2 facilitates miRNA function 
through posttranslational modification of the miRISC co-factor CGH-1, and C.elegans Y-
box protein-1 (CEY-1), a conserved RNA binding protein, specifically antagonizes the 
let-7 miRNA pathway. 
CHAPTER 1 provides an introduction to the mechanics and biological significance of 
the miRNA pathway, including a summary of the historical significance and utility of the 
study of miRNAs in C. elegans and the importance of understanding miRNA regulation 
in the context of human disease. This chapter also highlights the gap in our current 
understanding of how the miRNA effector complex, miRISC, is regulated.  
CHAPTER 2 highlights research done in collaboration with Ting Han and Vishal 
Khivansara. It characterizes the novel role of the highly conserved protein kinase, 
casein kinase II (CK2), in promoting target binding and repression by miRISC. Ting 
initiated the project and he and Vishal characterized the role of CK2 in the miRNA 
pathway using both genetic and biochemical approaches. Ting also identified the 
conserved miRISC co-factor CGH-1 as a potential CK2 substrate. My contribution to 
this project was the functional characterization of CK2 modification of CGH-1 in the 
miRNA pathway. There were several other collaborators on this project including: 
James Moresco, Patricia Tu, and John Yates who contributed mass spectrometry 
analyses; Mallory Freeberg who performed computational analysis of miRNA 
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expression levels; and Xantha Karp and Eric Montoye who provided additional 
phenotypic analyses. The manuscript, which I am co-first author on with Ting and 
Vishal, is currently in review at Proceedings of the National Academy of Sciences. 
CHAPTER 3 represents an independent venture to characterize the role of CEY-1 in the 
miRNA pathway. Based on an observation made shortly after I joined the Kim lab, the 
development of this project not only marks an endeavor to understand how CEY-1 
antagonizes the activity of the microRNA let-7, but also the effort to become proficient in 
a range of genetic, molecular and biochemical techniques required to interrogate the 
miRNA pathway in C. elegans. I formed several collaborations on this project including: 
Ting Han and Mallory Freeberg who performed and analyzed CEY-1 HITS-CLIP, 
respectively; Vishal Khivansara who performed RIP experiments and provided 
invaluable scientific and technical advice; and Xantha Karp and Eric Montoye who 
designed and performed let-7 sister and post-dauer phenotypic analyses. 
CHAPTER 4 concludes the dissertation with a discussion of future research directions. 
Appended is a description of the identification and characterization of the functional 
HEN1 ortholog of C. elegans, HENN-1. Published in PLoS Genetics in 2012. I 
contributed to this project by characterizing the expression and localization of HENN-1 
and ERGO-1 in the C.elegans germline by immunofluorescence.  
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 NOMENCLATURE 
 
Below is a summary of the standard conventions that apply for genetic nomenclature in 
C. elegans [1,2]  that are relevant for this dissertation. 
 
Genes 
Currently all C. elegans genes are assigned a sequence name corresponding to the 
genomic fragment from which they were sequenced, for example, F33A8.3 represents 
the third gene in the genomic fragment it was identified in. Genes can also be given a 
second name based on mutant phenotype, gene class, homology, etc… that consists of 
three or four lowercase italicized letters, a hyphen, and an italicized Arabic number, for 
example, F33A8.3 is also called cey-1, indicating it is the 1st identified member of the 
cey gene class. 
 
mRNA and microRNAs 
Messenger RNAs for named genes are written in lowercase italicized letters, for 
example, the gene and mRNA made from the lin-41 locus are both called lin-41. 
 
Mature microRNAs are written miR- , followed by the number of the mir gene from 
which they are transcribed, in line with conventions described in [3]. A handful of 
historical microRNAs, which are especially relevant to this dissertation, are referred to 
by their gene name in lowercase italics. Thus all species of the miRNAs let-7, lin-4, and 
lsy-6 are indicated thus. 
 
Proteins 
The protein product of a gene is the gene name written in non-italic capitals, for 
example, the protein encoded by lin-41 is LIN-41. 
 
! xiii!
Mutants 
Mutations are named using of one or two lowercase italicized letters followed by an 
italicized Arabic number, where the letter refers to the laboratory in which the mutation 
was isolated. Mutations are listed in parentheses after the gene name, for example, 
cey-1(ok1805) or let-7(n2853). Multiple mutations in a single background are listed by 
order of the chromosome they reside on, separated by a semicolon, for example, cey-
1(ok1805); let-7(n2853) indicates the double mutant, since cey-1 is on chromosome II 
and let-7 is on chromosome X. 
 
Phenotypes 
A phenotype can be described in words or abbreviated with a 3 or 4 letter non-italicized 
designation, where the first letter of a phenotypic abbreviation is capitalized, for 
example, phenotypes described in this dissertation include Rup for vulval rupture, Muv 
for multiple vulva, and Emb for embryonic lethality. !
REFERENCES 
1. Horvitz HR, Brenner S, Hodgkin J, Herman RK (1979) A uniform genetic 
nomenclature for the nematode Caenorhabditis elegans. Molecular & general 
genetics : MGG 175: 129-133. 
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CHAPTER 1 
Introduction to the microRNA field and regulation of the miRNA  
effector complex, miRISC 
 
ABSTRACT 
Over the past two decades microRNAs (miRNAs) have emerged as pervasive, 
conserved, post-translational regulators of gene expression that function in diverse 
biological settings. While significant strides have been made in characterizing the 
biogenesis and gene silencing mechanisms of miRNAs, the regulation of miRNA activity 
is less well understood. Foremost, a gap in knowledge exists in understanding how the 
conserved, ribonucleoprotein miRNA effector complex, called the miRNA-induced 
silencing complex (miRISC), is regulated. The importance of closing this gap is 
underlined by the essential nature of miRNAs in controlling diverse biological processes, 
including cell proliferation and differentiation, signaling, metabolism and apoptosis [1,2], 
and the disease-associated outcome of their dysregulation [3,4]. 
 Historically C. elegans has been an important model system for the study of 
miRNAs: the first miRNAs, lin-4 and let-7, were discovered in genetic screens for factors 
that controlled the timing of cell division and differentiation [5,6,7]. Today the robust and 
facile genetics of C. elegans and the ability to use it in high-throughput methods 
continue to make the worm an attractive in vivo system for characterizing factors that 
regulate miRNA silencing. 
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 The work presented in this dissertation describes the identification and 
characterization of two factors that regulate miRNA silencing in C. elegans: the 
conserved serine/threonine protein kinase CK2 and the RNA binding Y-box/cold-shock 
domain protein CEY-1. 
 
Conservation and biological importance of microRNAs  
MiRNAs are a highly conserved group of post-translational regulators that are involved 
in crucial processes during animal development, including the differentiation of 
embryonic stem cells, body patterning, and organ formation [1,3]. Regulation by 
miRNAs has also been associated with areas important to human health, including 
longevity [8], learning and memory [9,10,11], and disease [1,3]. Notably, recent studies 
in mouse models of human disease indicate that aberrant miRNA function [12] or 
mutations in their processing factors [13,14] contribute to the pathogenesis of common 
diseases, including cancer, cardiovascular disease [15], and type 2 diabetes [16]. 
Therefore, a detailed understanding of how miRNAs regulate gene expression holds the 
promise of informing our ability to prevent, diagnose, and treat common human 
diseases.  
To date, over 35,000 miRNAs have been discovered in 223 species, including 
more than 2,500 miRNAs in human [17]. In addition to being abundant, genome-wide 
studies estimate that miRNAs may target up to half of the human transcriptome [18]. 
Remarkably, despite over 500 million years of evolutionary divergence, about one-third 
of the approximately 250 identified miRNAs in C. elegans share sequence homology 
with vertebrate miRNA families [19]. Homologous miRNAs, within and between species, 
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have been grouped into families based on conservation of the “seed” sequence 
(nucleotides 2–8 at their 5′ end), which provides specificity to miRNA regulation [19,20]. 
Members of the same miRNA family often have similar spatial and temporal expression 
patterns, suggesting that their sequence conservation is tied to a common regulatory 
function [21,22,23,24,25]. A striking example of miRNA conservation is the let-7 family, 
which is highly conserved from C. elegans to humans [22]. There are thirteen let-7 
family members in human and nine in C. elegans [26,27]; human let-7a has perfect 
complementarity with C. elegans let-7 (Fig 1-1A). The let-7 family has conserved 
functions in regulating cellular differentiation and development. In C. elegans, let-7 and 
its family members, mir-48, mir-84, and mir-241, have well characterized roles in 
promoting C. elegans larval development [28]. D. melanogaster development is also 
regulated by its single let-7 [29,30,31] and in other organisms let-7 expression increases 
during development [21,22,23]. 
 
MicroRNAs in human disease  
In view of the essential nature of miRNAs in regulating critical biological processes, it is 
not unexpected that aberrant miRNA expression could affect those processes with 
pathological results. While a wide range of studies have correlated miRNA 
dysregulation with disease states, causality of miRNA dysfunction is not always clearly 
established. Nevertheless, a survey of several common diseases that have evidence of 
miRNA dysregulation include cancer, neurodegenerative, immunological, and 
cardiovascular disorders, and diseases associated with viral infections  (Table 1-1). The 
need for improved therapeutic intervention in all of these examples would greatly benefit 
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from a better understanding of the mechanisms and regulation of miRNA silencing 
activity. 
 Compelling work recently demonstrated that distinct miRNA expression profiles 
were associated with specific cancer types, and reflected the developmental lineage 
and differentiation state of tumors [32]. In agreement, previous studies reported that 
human miRNAs were frequently located in fragile sites and deleted or misexpressed 
[33,34], and scores of subsequent profiling studies suggest that tumors universally 
exhibit miRNA dysregulation [35]. In addition to specific miRNAs, mutations in miRNA 
machinery are also implicated in cancer. Haploinsuficiency caused by mutations in 
DICER, an enzyme required for miRNA biogenesis, is correlated with a variety of 
nonepithelial ovarian tumors, presumably due to a loss of miRNA-mediated gene 
regulation [36]. 
Consistent with its conserved role in regulating cell proliferation and 
differentiation during development, the dysregulation of let-7 is a feature of many types 
of cancers [37]. MiRNAs, like let-7, that function to balance of cell proliferation and 
differentiation exercise considerable influence in cancer networks, acting as tumor 
suppressors (e.g. let-7, miR-15-16, miR-26a, miR-146a) or oncogenes/oncomiRs (e.g. 
mir-17-92, -21, -29, -155) [38,39]. Extensive research in lung and other cancers show 
that let-7 is commonly down-regulated, resulting in increased expression of several key 
target mRNAs, including the oncogenes RAS and HMGA2 in lung cancer cells and MYC 
in Burkitt lymphoma cells [40,41,42,43,44,45,46].  
Direct evidence for miRNA function in tumor formation comes from recent in vivo 
mouse studies that demonstrate that artificial induction of miR-21 and miR-155 is 
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sufficient to induce lymphomagenesis [12,47], and that expression of the miR-17-92 
polycistronic miRNA accelerates Myc-induced B cell lymphomagenesis [48,49]. 
Conversely, therapeutic delivery of tumor suppressor miRNAs has been found to 
effectively inhibit tumor formation [50]. For example, systemic delivery of the let-7 tumor 
suppressor miRNA inhibits lung tumors in mice [51], and viral delivery of miR-26a 
inhibits hepatocarcinoma in mouse models [52].  
Thus, understanding how miRNA-mediated gene silencing is regulated promises 
to  aid our understanding of the etiology of common human diseases, perhaps revealing 
new avenues for diagnosis, treatment, and, ideally, prevention. 
 
Historical significance of miRNAs in C. elegans  
C. elegans lin-4 and let-7 were the first identified miRNAs [5,6,7]. Although let-7 was 
discovered second, it was its deep sequence conservation and common temporal 
expression patterns among metazoans that first suggested that miRNAs were not a C. 
elegans-specific phenomenon [22]. lin-4 and let-7 were initially discovered in forward 
genetic screens designed to identify genes that control developmental timing and 
differentiation (i.e. the “heterochronic” pathway) [5,6,7]. C. elegans have invariant cell 
lineages that have been completely mapped from embryo to adult [53,54]. Thus, the 
temporal displacement of specific lineage events can be identified relative to the 
boundaries established by the transition between each of the four larval stages (L1, L2, 
L3 and L4), which are punctuated by a molting cycle.  
let-7 was identified as a retarded heterochronic factor whose mutant phenotype 
suggested it promoted the L4-to-adult-transition [7]. let-7 null mutations are not viable 
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(hence “let”-7 for lethal), however studies of a series of weak mutations (i.e. 
hypomorphs) of let-7 indicate that reduced let-7 function results in the failure to adopt 
adult cell fates. Specifically, let-7 hypomorphs exhibit reiteration of larval molting and 
hypodermal seam cell division patterns and compromised vulval integrity. The latter 
defect results in a dramatic ruptured vulva phenotype, where animals herniate through 
their vulva and ultimately die [7]. Genetic and molecular evidence suggest that the most 
biologically relevant target of let-7 in C. elegans is lin-41 [55], which encodes a 
TRIM/RBCC family protein homologous to human TRIM71 [56], that negatively 
regulates expression of LIN-29, a transcription factor required for adult cell fate 
specification [57] (Fig 1-1B). Hence, let-7 regulation acts as a developmental switch: 
beginning in late L3, let-7 levels rise dramatically, triggering the rapid degradation of lin-
41 mRNA at the L4-to-adult transition [57,58] (Fig 1-1C). Other let-7 targets include the 
C. elegans hunchback ortholog, hbl-1 [59], and mRNAs encoding several transcription 
factors, including the nuclear hormone receptor daf-12, the forkhead transcription factor 
pha-4, and the zinc finger protein die-1 [60].  The homolog of the oncogene RAS, let-60, 
is also regulated by the let-7 family [41]. 
Three other C. elegans let-7 family miRNAs have been characterized in the 
regulation of C. elegans development:  mir-48, mir-84, and mir-241 [28] (Fig 1-1A). 
These let-7 “sisters” cooperatively function in a temporally distinct manner from let-7, 
promoting the L2-to-L3 transition, through the negative regulation of hbl-1 and daf-12 
[7,28,61] (Fig 1-1B). 
 
C. elegans: a powerful model system for studying the miRNA pathway 
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In addition to the insights gained by characterizing let-7 in C. elegans, let-7 has also 
proven a useful genetic tool for identifying additional genes required for the miRNA 
pathway. Hypomorphic alleles of let-7 provide obvious observable phenotypes that can 
be enhanced or suppressed to identify genes that positively or negatively affect the 
miRNA pathway, respectively. To date, several screens have identified genes encoding 
novel factors, including additional let-7 targets [62], the exonuclease XRN-2, which 
accelerates the turnover of mature let-7 molecules [63], and genes involved in circadian 
rhythms [64], cell cycle regulation [65], and membrane trafficking [66]. Genome-wide 
RNAi screens [65,67,68,69] have also identified a host of candidates, the majority of 
which await molecular characterization.  
 In addition to let-7-based assays, several other miRNAs in C. elegans have known 
targets, and mutants with distinct phenotypes that can also be used to investigate 
miRNA function: miR-1, a conserved muscle-specific miRNA, regulates targets that 
affect pre- and post- synaptic function at neuromuscular junctions [70];  lin-4 regulates 
the timing of fate specification in neuronal and hypodermal lineages in early larval 
development [5,71]; and lsy-6 specifies the neuronal fate of one of two bilaterally 
symmetric chemosensory neurons [72].  
 Since miRNAs have largely conserved machinery for their biosynthesis, 
processing, and silencing functions, factors identified in C. elegans commonly have 
functional equivalents in other species. Therefore, despite its simplicity, C. elegans is a 
powerful tool for in vivo analysis of the miRNA pathway. 
 
MicroRNA biogenesis and post-translational gene silencing  
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Canonical miRNA biogenesis  
Most miRNA genes are initially transcribed by RNA polymerase II as long primary 
transcripts (pri-miRNA) [73,74] (Fig 1-2A). Like mRNAs, pri-miRNAs are capped, 
polyadenylated, and may be spliced [73,75]. Pri-miRNAs undergo sequential processing 
by the RNase III enzymes, Drosha and Dicer. First, within the pri-miRNA, a predicted 
stem-loop hairpin structure is excised by Drosha (Pasha in fly and worm), to yield a ~70 
nt precursor miRNA (pre-miRNA) [76,77,78] (Fig 1-2A). Drosha cleavage is directed by 
DGCR8 (DiGeorge critical region gene 8), which recognizes the point where the single-
stranded transcript transitions into the double-stranded hairpin [79]. Alternatively, some 
pre-miRNAs are produced from very short introns, known as mirtrons, as a result of 
splicing and debranching, and therefore bypass the Drosha-DGCR8 processing step 
[80]. Pre-miRNAs are transported into the cytoplasm by Exportin-5, a member of the 
karyopherin family of proteins, which mediates transport between the nucleus and 
cytoplasm, by a Ran-GTP-dependent mechanism [81,82,83]. Pre-miRNAs are further 
cleaved into a ∼22 nt miRNA duplex by Dicer [84,85,86], which cooperates with the 
TRBP (human immunodeficiency virus transactivating response dsRNA binding protein; 
Loquacious in fly) [87,88,89] (Fig 1-2A). Finally, the miRNA strand with the lower 
relative base-pairing stability at its 5′ end is preferentially incorporated as the mature 
miRNA into an Argonaute protein, which forms the core of the miRNA-induced silencing 
complex (miRISC) [90,91] (Fig 1-2A). The heat shock proteins HSP70 and HSP90 
mediate the ATP-dependent loading of miRNA duplexes by Argonautes [117]. MiRNA 
loading is also facilitated by DICER, TRBP, and PACT (protein activator of the interferon 
induced protein kinase), which form a miRNA-loading complex [92,93,94].  
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Components of the miRNA-induced silencing complex  
The Argonaute protein that forms the core of miRISC, AGO1-4 in humans, AGO1 in 
Drosophila, and ALG-1/2 in C. elegans [84,95,96], are part of a highly conserved family 
of small RNA binding proteins that are essential components of RNA-silencing 
pathways, including the miRNA, piRNA, and endogenous and exogenous siRNA 
pathways [97]. Despite their unusual moniker, Argonaute proteins were named using 
traditional genetic nomenclature: the Arabidopsis AGO1 mutant phenotype resembles 
the octopus Argonauta argo [98]. Incidentally, the octopus was named based on folk 
tales that female of the species could glide across the ocean’s surface using her egg 
cases as a boat and her webbed legs as sails, recalling the Argo, a giant wooden sailing 
vessel of Greek mythology, manned by Jason and the Argonauts [99]. 
 The miRNA-bound Argonaute associates with several protein cofactors to form 
miRISC. The glycine-tryptophan (GW) protein of 182 kD (GW182; AIN-1/2 in worms) is 
an important scaffolding factor that is responsible for localizing Argonaute to P-bodies, 
major cytoplasmic centers for mRNA catabolism, which co-localize with the decapping 
factors DCP-1/2 and the 5’-to-3’ nuclease XRN-1 [100,101,102,103,104,105]. In C. 
elegans, ALG-1 and AIN-1/2 are required for miRNA-mediated translational repression 
and mRNA target degradation [106] (Fig 1-2B). Work in mammalian systems revealed 
that the GW motifs of GW182 proteins associate with the CCR4/NOT deadenylase 
complex and the PAN2/3 nucleases, which function in translational repression [107,108]. 
GW182 homologs also associate with the EDD E3 ubiquitin ligase, which associates 
with the Transducer of ERBB2 EGF Receptor (TOB1/2) and the Dead Box helicase 
DDX6 (CGH-1 in worms) [109]; TOB1/2 acts to physically link CCR4 and the PolyA 
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Binding Protein (PABP) to promote deadenylation [110], and DDX6 promotes miRISC 
by interaction with the CCR4-NOT and other mRNA degradation machinery 
[111,112,113]. In C. elegans, the DDX6 ortholog, CGH-1, and the TRIM-NHL ubiquitin 
ligase NHL-2 are also required for effective miRISC target silencing [114].  In 
mammalian systems the NHL-2 homolog, TRIM32, has been shown to enhance the 
activity of let-7 bound miRISC [115]. Lastly, proteomic analyses in C. elegans have 
identified additional factors associated with miRISC, including the fly Vasa Intronic Gene 
ortholog, VIG-1, and the Tudor domain protein, TSN-1, which are both required for 
silencing of a let-7 target 3’ UTR reporter [116]. 
Mechanisms of miRNA-mediated target silencing 
Once incorporated into miRISC, the miRNA provides target specificity; miRNAs identify 
mRNA targets through base pairing interactions with partially complementary sites 
predominately located in the 3’UTR of the target mRNA, then miRISC directs their 
silencing [117,118,119]. Thus, loss of miRNA regulation leads to elevated mRNA and 
protein expression of targets. If target up-regulation results in a physiological or 
pathological phenotype it can be ameliorated, in an experimental setting, using RNAi-
based strategies to reduce target levels.  
MiRISC has been reported to affect silencing by both translational repression 
and/or mRNA decay (Fig 1-2B). However, a global rule governing the temporal order 
and/or relative contribution of the silencing mechanisms has not been established [120]. 
In support of translational repression, ribosome profiling in C. elegans and in human 
cells suggests that upon loss of let-7 its target mRNAs shift from monosomes to 
polysomes, suggesting that let-7 blocks translation initiation [106,121]. Interestingly, the 
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shift is 5’ cap-dependent [122,123], consistent with evidence that the human Argonaute, 
Ago2, can compete with eIF4E, a translation initiation factor, for cap binding [124]. In 
agreement, luciferase reporter studies indicate that translational repression often occurs 
in the absence of mRNA degradation, or before the onset of mRNA degradation 
[125,126,127]. 
In contrast, global profiling of actively translating ribosomes suggests that 
decreased levels of target mRNAs may account for much of the silencing attributed to 
miRISC [128,129]. Further support for miRNA-mediated target degradation stems from 
several reports that connect deadenylation and subsequent decapping with miRISC 
silencing [125,130,131,132,133]; through GW182-mediated interactions, miRISC 
associates with the polyA-binding protein PABPC [100,104,134,135] and the CCR4-
NOT deadenylase complex to initiate polyA tail shortening and degradation [130,134] 
(Fig 1-2B). 
Intriguingly, studies in zebrafish suggest that miRNA-mediated deadenylation in 
pre-gastrulation-stage embryos triggers translational repression without RNA decay, 
while RNA decay accompanies decreased translation in later stages and in vitro [146-
149]. Notably, mRNA poly-A tail length is positively correlated with translation rate in 
early embryos, which disappears after gastrulation [147]. Therefore, it appears that 
miRNA-mediated silencing may occur by different mechanisms during development.                                                                              
While it is evident that several mechanisms are employed to achieve miRNA-mediated 
silencing, it is likely that both mRNA degradation and translational repression contribute 
to miRNA target silencing. However, what dictates the predominant means of silencing 
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appears complex and may be dependent on the miRNA and target, experimental 
system and/or the developmental context. 
Regulation of the miRNA-Induced Silencing Complex  
Factors that regulate miRNAs have been identified at nearly every step in the pathway 
[136]. Due to the scope and focus of this dissertation, emphasis will be placed on the 
describing what is known about the regulation of miRISC, specifically on recent findings 
that highlight the underexplored areas of post-translational modification to miRISC and 
the interaction of miRISC with RNA binding proteins. 
Regulation of miRISC through post-translational modification  
Post-translational protein modifications play important roles in regulating protein stability 
[137], protein-protein interactions, and cell signaling and regulatory processes [138]. A 
limited number of reports functionally implicate post-translational modification in the 
regulation of miRISC [139]. Understandably, particular focus has been devoted to the 
modification of Argonaute as it is the central component of miRISC. Phosphorylation of 
human Ago2 at S387 and Y529 has been demonstrated to affect P-body localization 
[140,141,142], modifications at Y529 also affect miRNA binding to Ago2 [140], and 
those at S387 affect miRNA-mediated translational repression [142]. Hydroxylation of 
human Ago2 at P700 has also been shown to be required for its stability, P-body 
localization, and silencing activity [143,144]. Additionally, ubiquitination of mouse Ago2 
by the TRIM-NHL protein Lin41 promotes its proteasome-mediated degradation [145]. 
Finally, ADP-ribosylation of all 4 human Agos has been reported to negatively regulate 
miRNA-mediated silencing under stress conditions [146]. Apart from Argonautes, there 
is scant evidence supporting functional post-translational modifications of miRISC. 
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Although phosphorylation of the human GW182 protein has been shown to reduce the 
efficiency of its association to PABP and subsequent silencing by miRISC [147]. 
Existing studies mainly support the consensus that post-translational modification can 
modulate protein stability and localization; few identify modifications that regulate 
miRISC activity. Therefore, the question of how miRISC is regulated by post-
translational modification remains a gap in our understanding of miRNA function. 
mRNA regulation by miRISC and RNA binding proteins 
A host of RNA binding proteins (RBPs) associate with the untranslated regions of 
mRNAs to regulate translation, stability, and turnover. The 3’UTR has proven a 
particularly rich region for binding and regulation. AU-rich elements (AREs), located in 
the 3’UTR, are bound by RBPs that affect transcript stability. For example, the RBPs 
AUF/hnRNP-D (AU-Rich Element RNA Binding Protein/heterogeneous nuclear 
ribonucleoprotein D), TTP (tristetraprolin), and KRSP (K homology Splicing Regulatory 
Protein) destabilize mRNA by recruiting deadenylation and decay factors [148,149,150], 
while others such as the Hu/ELAV family proteins primarily function to stabilize 
transcripts by promoting translation and competing with negative regulatory factors 
[151,152]. The highly conserved PUF (Pumilio-fem-3 mRNA binding Factor) family 
proteins also elicit translational repression through association with specific motifs in the 
3'UTR of target mRNAs [153]. 
 As the primary site of miRNA regulation, the 3’UTR of miRNA-targeted mRNAs 
may also be occupied by RBPs that may, directly or indirectly, affect miRNA-induced 
silencing. The interaction of miRNAs and RBPs has been referred to as the “post-
transcriptional regulatory code” [154]. However, despite having such a definitive 
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description, this “code” is poorly understood. Foremost, only a relatively small proportion 
of proteins with RNA binding domains have been functionally characterized. It is 
estimated that RNA sequence motifs are known for only ~15% of human and ~3% of C. 
elegans proteins that have identified RNA-binding domains [155]. Thus, further 
characterization of the RBP-miRNA interactome is required to fill the gap in our 
understanding of post-translational regulatory dynamics.  
 Several key studies have highlighted the importance of miRNA-RBP interactions, 
characterizing RBPs that affect miRISC activity. For example, DND1 (DND miRNA-
mediated repression inhibitor 1) prevents target mRNA silencing by several miRNAs, 
including miR-221 and miR-430, in human and zebrafish primordial germ cells by 
binding to mRNA sequences that overlap with miRNA binding sites, which prevents 
miRISC accessibility and silencing [156]. In contrast, PUF family proteins, which are 
negative post-transcriptional regulatory factors, are implicated in facilitating miRISC. In 
C. elegans, PUF-9 promotes let-7 repression of a shared target mRNA [157] and 
interacts with miRISC in an RNA-dependent manner (Yang, D. et al., unpublished data). 
This relationship may be conserved as targets of human PUFs are enriched for miRNA 
sites near PUF binding motifs [158].  
 Interestingly the nature of the relationship of some RBPs with miRISC appears to 
be dependent on the proximity of their binding sites. For example, HuR/ELAV has been 
extensively characterized as a miRISC antagonist [159]. However recent studies that 
compared transcriptome-wide HuR and miRNA interactions on co-targeted mRNAs 
suggest a distance-dependent regulatory relationship [160,161]: when HuR/ELAV 
binding sites overlap with miRNA target sites, HuR generally prevents miRISC 
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accessibility and silencing, whereas more distally located binding sites are primarily 
regulated by miRISC. Intriguingly, several studies have reported that HuR facilitates 
miRISC silencing of specific shared targets when their respective binding sites are non-
overlapping, including MYC, p16, and RhoB mRNAs [162,163,164]. Two additional 
examples of RBPs that differentially modulate miRISC are PTB (polypyrimidine-tract-
binding protein) and the helicase MOV10 (Moloney leukemia virus 10). PTB competes 
with miRISC when their binding sites overlap but appears to facilitate miRISC access by 
melting secondary structure when their binding is adjacent [165]. MOV10 facilitates 
miRISC binding by unwinding G-rich secondary structure, but limits miRISC accessibility 
on mRNAs also bound by the Fragile X Mental Retardation Protein (FMRP) [166]. 
Identification of novel miRISC regulatory factors 
The work presented in this dissertation describes the identification and characterization 
of two factors that regulate miRNA silencing in C. elegans in opposing fashions: Casein 
Kinase II (CK2) promotes miRNA function while the RNA binding protein C. elegans Y-
box Protein 1 (CEY-1) antagonizes it.  
Casein Kinase II (CK2) 
Named for its misidentification as a casein kinase, CK2 is a serine/threonine kinase that 
is ubiquitously conserved in eukaryotes. Over the past three decades an impressive 
amount of research has been dedicated to defining the molecular, biochemical and 
physiological functions of CK2 (reviewed in [167,168,169,170,171,172]). Dubbed the 
“master regulator” of cell function, biochemical and functional analyses suggest that 
CK2 is capable of phosphorylating over 300 proteins in human that are implicated in the 
regulation of many cellular functions, including protein and nucleic acid synthesis, cell 
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growth, proliferation and death, signal transduction pathways, neuronal function, 
angiogenesis, and organogenesis [167,173]. Unsurprisingly, given its involvement in 
such a diverse range of essential processes, genetic analysis has demonstrated that 
CK2 is essential for cell viability in yeast, embryonic development in mice, and for post-
embryonic development in C.elegans [174,175,176,177]. 
In animals, CK2 functions in a hetero-tetrameric complex composed to 2 
regulatory β subunits and two catalytic α subunits arranged in an α2β2 configuration 
[178] that phosphorylates substrates harboring the S/TXXD/E motif. However, unlike 
many kinases, which require activation (i.e. priming phosphorylation) and function in 
networks or cascades, CK2 appears to require no such activation and thus has been 
traditionally defined as a constitutively active kinase [167]. Therefore, how (and if) CK2 
is regulated is a critical and yet unresolved question, highlighted by a large body of 
literature reporting CK2 function in disease and cancer biology. 
We first identified CK2 in a genome-wide RNAi screen to discover novel factors 
in small RNA-mediated gene silencing pathways in C. elegans [68]. A relationship 
between CK2 and the miRNA pathway has not been reported. Since the significance of 
post-translational modifications to proteins in the miRNA pathway is not well understood, 
we employed a combination of genetic and molecular techniques to investigate CK2 
function in the miRNA pathway. Our findings are the subject of CHAPTER 2: Casein 
kinase II promotes target silencing by miRISC through direct phosphorylation of 
the DEAD-box helicase CGH-1.  In short, we find that CK2 genetically and physically 
interacts with miRISC and promotes miRISC target association. We identify the 
conserved miRISC component, the DEAD-box helicase CGH-1, as a direct CK2 
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substrate and demonstrate that CK2 phosphorylation of CGH- 1 is important for its 
function in the miRNA pathway. 
C. elegans Y-box Protein 1 (CEY-1) 
CEY-1 is part of a family of 5 RNA binding Y-box proteins in C.elegans that also 
includes CEY-2, CEY-3, CEY-4, and LIN-28. Over two decades ago, the CEYs were 
identified by domain homology [179]. However, until recently, little was known about 
their function in C. elegans. In contrast, Y-box proteins (YBPs) have been extensively 
characterized in other model systems. YBPs function in a variety of cellular processes 
that involve the regulation of mRNA stability, translation, and/or localization. Notably, 
YBPs are essential for proper gametogenesis, as characterized in a host of model 
organisms, including YB1 in human [180], YBX2/MSY2 in mouse [181,182], FRGY2 in 
frog [183], Ypsilon schachtel (Yps) in fly [184], Ybx1 in fish [185], and CEY-2/-3 in worm 
[186].  
The somatic function of Y-box proteins has been most extensively explored in the 
human Y-box protein, YB-1/YBX1. Since YB-1 overexpression in multiple human 
cancers is associated with increased proliferation, tumor aggressiveness, and drug 
resistance (reviewed in [187,188]), the mechanism and regulation of its functions are of 
therapeutic interest. YB-1 has been implicated in a range of biological processes, 
including DNA repair, stress response, and, most notably, in the regulation mRNA 
transcription, splicing, translation and stability [187,189]. In general, YB-1 appears to 
promote mRNA stability and translation: it binds mRNA and associates with mRNP 
granules [190,191], sites of mRNA sequestration and storage, and has also been shown 
to positively regulate translation by transporting mRNA to polysomes [192].  
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We first became interested in CEY-1 when we observed that loss of cey-1, but 
not other ceys, potently suppressed lethal phenotypes associated with loss of the 
miRNA let-7. Recent findings have highlighted the importance of increasing our 
understanding of the interplay of RNA binding proteins and miRISC in mRNA regulation. 
Since Y-box proteins have yet to be connected to miRNA regulation, we investigated 
the role of CEY-1 in the miRNA pathway. Complementary genetic, biochemical, and 
molecular analysis of CEY-1 suggest that it specifically antagonizes let-7 miRISC 
activity, possibly through association with the 3’UTR of let-7 targets. Our findings are 
discussed in detail in CHAPTER 3: CEY-1 attenuates let-7 microRNA-mediated gene 
silencing in C. elegans. 
 
SUMMARY 
MiRNAs are highly conserved negative regulators of gene expression that influence a 
wide range of cellular and developmental events. Their essential involvement in a wide 
range of biological processes, including cellular proliferation and differentiation, has also 
implicated miRNAs in human disease. Although fundamental insights have illuminated 
the mechanisms of miRNA biogenesis and gene regulation, we have only a rudimentary 
understanding of how the miRNA effector complex, miRISC, is regulated. In this regard, 
post-translational modification to miRISC and the cooperative regulation of a common 
set of mRNAs bound by miRISC and other RNA binding proteins are two underexplored 
areas of interest. Historically, C. elegans has played a significant role in the discovery 
and characterization of miRNAs and the miRNA pathway. Today C. elegans continues 
to be a powerful model system for identifying factors that regulate the miRNA pathway. 
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The work presented in this dissertation describes the identification and characterization 
of two novel factors that regulate miRISC in C. elegans, Casein Kinase II and CEY-1. 
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Figure 1-1. let-7 family miRNAs in C. elegans. (A) Alignment of mature human let-7a 
and the members of the C. elegans let-7 family. The miRNA seed is indicated in red. let-
7 family members with characterized functions in regulating C. elegans development, in 
green. (B) Genetic diagram of the let-7 regulatory network. miRNAs are in green, their 
mRNA targets are in black. (C) Cartoon depiction of let-7 regulation of lin-41 mRNA at 
the L4 to adult transition. 
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Figure 1-2. The miRNA pathway. (A) Cartoon depicting the major steps in miRNA 
biogenesis. (B) Cartoon depicting miRISC binding and silencing of an mRNA target. 
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Table 1-1. miRNAs associated with common human disease.* 
   Disease  MiRNAs implicated Reference  
Cancer    
Breast miR-23b/27b/24; miR-34a [193], [194] 
Chronic lymphoid leukemia miR-15, miR-16 [33] 
Colorectal & Pancreatic miR-155 [195], [196] 
Gastric miR-25, miR-29, miR-93, miR-106b; mir-181c [197], [198] 
Liver miR-7, miR-29b 
[199], 
[199,200] 
Lung miR-34, miR-155 [201], [202] 
Prostate miR-143, miR-145 [203] 
Multiple let-7 family 
reviewed in 
[37] 
Multiple miR-21 [204], [12] 
Neurodegenerative 
  
Alzheimer’s 
miR-9, miR-29b-1, miR-29a; miR-139-5p, 
miR-3470a [205], [206] 
Parkinson’s miR-7, miR-34b/34c, miR-133b, miR-153 
reviewed in 
[207] 
Immunity 
  
Multiple sclerosis miR-34a, miR-145, miR-155, miR-326 
[208], [209], 
[210] 
Systemic lupus 
erythematosus miR-146a [211] 
Type II diabetes miR-29 family, miR-103, miR-107 [212], [213] 
Cardiovascular 
  Cardiac arrhythmia miR-1 [214] 
Cardiac hypertrophy miR-150, miR-181b, miR-195 [215] 
Cardiac fibrosis miR-29 [216] 
Metabolic & Cholesterol 
Regulation miR-33, miR-133 [217],[218] 
Viral 
  
HIV-1 
miR-28, miR-125b, miR-150, miR-223, miR-
382 [219] 
Hepatitis C miR-122 [220] 
Influenza viruses 
miR-21, miR-22, miR-30b-d, miR-200a, miR-
223, let-7f [221], [222] 
* adapted from Ardekani and Naeini [223] 
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ABSTRACT 
MicroRNAs (miRNAs) play essential, conserved roles in diverse developmental 
processes through association with the microRNA-Induced Silencing Complex 
(miRISC). While fundamental insights into the mechanistic framework of miRNA 
biogenesis and target gene silencing have been established, post-translational 
modifications that affect miRISC function are less well understood. Here we report that 
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the conserved serine/threonine kinase, casein kinase II (CK2), promotes miRISC 
function in Caenorhabditis elegans. CK2 inactivation results in developmental timing 
defects that phenocopy loss of miRISC cofactors and enhances the loss of miRNA 
function in diverse cellular contexts. While CK2 is dispensable for miRNA biogenesis 
and the stability of miRISC cofactors, it is required for efficient miRISC target mRNA 
binding and silencing. Importantly, we identify the conserved DEAD-box RNA helicase, 
CGH-1/DDX6, as a key CK2 substrate within miRISC and demonstrate phosphorylation 
of a conserved N-terminal serine is required for CGH-1 function in the miRNA pathway.  
 
SIGNIFICANCE STATEMENT 
MicroRNAs are critical regulators of diverse biological processes. Despite rapid 
advances in understanding microRNA biogenesis and function, a gap remains in our 
knowledge of how microRNA effector complex activity (miRISC) is modulated. 
Specifically, the importance of post-translational protein modifications in controlling 
miRISC activity remains largely unexplored. Here, we characterize a novel role for the 
conserved serine/threonine kinase, casein kinase II (CK2), in promoting the miRNA 
pathway in C. elegans. Notably, we establish the requirement of CK2 for miRNA 
function and provide mechanistic evidence that loss of CK2 compromises miRISC 
binding to mRNA targets. Furthermore, we identify that the miRISC cofactor and DEAD-
box RNA helicase, CGH-1/DDX6, is phosphorylated by CK2 at a conserved residue, 
which is required for CGH-1-mediated miRNA function.  
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INTRODUCTION 
Since the discovery of lin-4 and let-7 in C. elegans, miRNAs have emerged as an 
evolutionarily conserved superfamily of small endogenous RNAs critical for post-
transcriptional gene regulation (Lee et al., 1993; Reinhart et al., 2000). MiRNAs regulate 
diverse biological processes including animal development, cell differentiation, 
apoptosis, and metabolism [1,2,3]. To date, at least 250 miRNAs have been identified in 
C. elegans and almost ten times as many in human [4]. Furthermore, miRNAs are 
predicted to target as much as half of the transcriptome, further underscoring their 
central role in post-transcriptional gene silencing mechanisms [5].  
MiRNAs are typically transcribed as long primary transcripts that are processed 
sequentially by the RNase III enzymes Drosha and Dicer to produce a ~70 nt precursor 
hairpin and a ~22 nt RNA duplex, respectively [6,7]. One strand of the duplex is 
selectively loaded as the mature miRNA into an Argonaute (Ago) family protein that 
forms the core of miRISC in conjunction with a GW182 family protein [6,7]. Partial base 
pairing of the miRNA with complementary sites predominantly located in the 3’UTR of 
target mRNAs leads to transcript destabilization, translational repression, or both [3,8].  
Through a combination of genetic and biochemical approaches, conserved miRISC 
factors have been identified in C. elegans including Argonaute-like genes ALG-1 and 
ALG-2, orthologs of human Ago2 [9]. Mutation of alg-1 results in pleiotropic phenotypes, 
consistent with loss of miRNA regulation in diverse biological pathways [9,10]. In 
contrast, alg-2 mutants are superficially wild-type, suggesting a partially redundant role 
in miRNA-mediated processes [10]. ALG-1 physically interacts with AIN-1 and AIN-2 
(ALG-1 interacting protein), functionally redundant orthologs of human GW182 [11,12]. 
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AIN-1/2 are required for the localization of ALG-1 to P-bodies, major cytoplasmic 
centers for mRNA catabolism and storage. Thus, AIN-1/2 function as a molecular link 
between target-bound miRISC and downstream machinery required for translational 
repression and degradation of target mRNAs [11,12].  
Activity of miRISC is facilitated by conserved cofactors that include the DEAD-
box RNA helicase CGH-1 and the TRIM-NHL ubiquitin ligase NHL-2. CGH-1 and its 
homologs are broadly involved in regulating mRNA stability and translation during 
development and differentiation in both somatic and germ cells [13,14]. In C. elegans, 
cgh-1 and nhl-2 are required for effective miRISC target silencing [15]. The human 
ortholog of CGH-1, DDX6, has been shown to promote miRISC by interaction with the 
CCR4-NOT deadenylase complex and mRNA degradation machinery [16,17,18]. The 
C. elegans miRISC also contains the fly Vasa Intronic Gene ortholog, VIG-1, and the 
Tudor domain protein, TSN-1, that have both been shown to be required for silencing of 
a let-7 target 3’UTR reporter [19]. 
Post-translational modifications (PTMs) have recently emerged as a potential 
mechanism for directly regulating miRISC activity [20].  To date, a limited number of 
studies have addressed the functional role of PTMs of miRNA pathway machinery. In 
particular, several PTMs to Argonaute have been characterized 
[21,22,23,24,25,26,27,28,29,30].  However, little is known about the identity and 
functional significance PTMs of other components of miRISC.  
Previously, we reported the identification of several signaling kinases including 
the conserved, constitutive serine/threonine kinase, casein kinase II (CK2), in a 
genome-wide RNAi screen for candidate factors involved in small RNA-mediated 
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silencing in C. elegans [31,32]. In this study, we characterize the role of CK2 as a 
positive regulator of miRISC activity in C. elegans. We provide evidence that CK2 
functions downstream of miRNA biogenesis and is necessary for efficient miRISC 
binding to target mRNAs. Furthermore, we demonstrate that CK2 is required for 
phosphorylation of the miRISC cofactor CGH-1, which was previously implicated in 
facilitating miRISC-target interactions [15]. Our data indicate that CK2 phosphorylation 
of CGH-1 at a conserved serine residue within an N-terminal CK2 motif is required for 
CGH-1 function in developmental pathways regulated by miRNAs. 
 
RESULTS 
The CK2 holoenzyme consists of two catalytic α subunits and two regulatory β subunits 
in a tetrameric α2β2 configuration [33]. In C. elegans, kin-3 and kin-10 encode the 
catalytic and regulatory subunits of CK2, respectively [34]. In addition to identifying kin-
10 in a genome-wide screen for factors required for RNAi [31], we identified both CK2 
subunits among factors that co-immunopurified with the GW182 homolog, AIN-1, by 
liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). In 
addition to other core miRISC factors (ALG-1, ALG-2, and CGH-1), we recovered one 
KIN-3 peptide (KVLGTDELYEYIARY; 3.6% sequence coverage) and two KIN-10 
peptides (RGNEFFCEVDEEYIQDRF, RFNLTGLNEQVPKY; 12% sequence coverage), 
suggesting that CK2 physically interacts with miRISC. 
 
CK2 regulates miRNA-dependent developmental timing 
To explore the possibility that CK2 regulates miRNA-dependent developmental timing, 
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we analyzed animals depleted of kin-3 or kin-10 for phenotypes associated with 
compromised miRISC function [9,11,15]. During post-embryonic development, C. 
elegans proceeds through four larval stages (L1-L4) before emerging as an adult. Loss 
of core miRISC factors results in reiteration of larval developmental patterns and failure 
or delay in the initiation of adult-specific programs. For example, formation of cuticle 
protrusions, termed alae, along the left and right sides of the adult animal requires the 
let-7 family of miRNAs [2,35]. We investigated if CK2 was required for the timing and 
proper formation of adult alae. Because CK2 is essential for viability, we used kin-3 and 
kin-10 RNAi (hereafter referred to as CK2 RNAi) to attenuate its expression (Fig 2-S1 
A,B). While wild-type animals on empty vector control RNAi display no alae defects, 
RNAi of CK2 results in penetrant adult alae defects similar to those observed in RNAi of 
alg-1, which encodes the primary Argonaute protein in miRISC (Fig 2-1A). Similarly, 
seam cells are generated through stem cell-like divisions during larval transitions, 
terminally differentiating in the adult to yield 16 laterally distributed seam cells on each 
side of the body [36] that can be visualized using a seam cell-specific GFP reporter [37]. 
Whereas wild-type animals invariably have 16 seam cells, animals subjected to CK2 
RNAi exhibit significantly increased numbers of seam cells, similar to animals depleted 
of miRISC components ALG-1, AIN-1, or NHL-2 (Fig 2-1B). These data indicate that 
CK2 is required for appropriate timing of seam cell divisions. Finally, we examined the 
timing of expression of a GFP reporter for the adult-specific collagen, COL-19, whose 
expression is controlled by miRNAs that regulate the heterochronic pathway [38] [39]. 
While only ~5% of adult animals on empty vector control RNAi display reduced Pcol-
19::gfp expression in hypodermal cells at the adult stage, 20-35% of adult animals on 
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CK2 RNAi exhibit reduced GFP reporter expression, comparable to RNAi of core 
miRISC factors (Fig 2-S2A). Taken together, these results indicate that, like miRISC 
components, CK2 is required for miRNA-mediated adult hypodermal remodeling during 
the larval-to-adult transition.  
 
CK2 promotes let-7 family and miRISC function 
To define further the role of CK2 in the miRNA pathway, we examined genetic 
interactions between CK2 and let-7 family miRNAs and miRISC components. Mild 
phenotypes elicited by hypomorphic mutations in miRNA pathway genes create 
sensitized genetic backgrounds that can be enhanced by mutations in other genes 
required for the pathway. Therefore we examined if loss of kin-3 or kin-10 could 
enhance phenotypes associated with hypomorphic mutations in genes of the miRNA 
pathway.  
In the transition period between each larval stage, C. elegans proceed through a 
quiescent state called lethargus, where animals cease pharyngeal pumping and reduce 
locomotion prior to molting. In retarded heterochronic mutants, lethargus is reiterated at 
the adult stage [2,35,40]. A mutant for mir-48, a member of the let-7 family of miRNAs, 
exhibits a low level of adult lethargus that is exacerbated by deleting its paralog, mir-84 
[35] (Fig 2-1C). In the mir-48(n4097) sensitized genetic background, adult lethargus is 
significantly enhanced by CK2 RNAi at levels comparable to RNAi of miRISC 
components (Fig 2-1C). Likewise, loss of let-7 activity leads to a rupturing (Rup) 
phenotype, in which animals herniate through the vulva and subsequently die [2]. Two 
hypomorphic let-7 alleles (mg279 and n2853) exhibit a mild Rup phenotype, which is 
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enhanced by CK2 RNAi at levels comparable to RNAi of miRISC components (Fig 2-
1D). let-7 family mutants, mir-48(n4097) and the mir-48(n4097); mir-84(n4037) double 
mutant [35], as well as core miRISC factor mutants, alg-1(tm369) and ain-1(ku322) 
[9,12] also display Rup phenotypes that are exacerbated by CK2 RNAi (Fig 2-1D). 
Together these data suggest loss of CK2 enhances mutant phenotypes of the let-7 
family of miRNAs. 
To rule out the possibility of off-target effects of RNAi, we confirmed 
enhancement of let-7 mutant phenotypes in kin-10 deletion mutants. CK2 is essential 
for C. elegans development: kin-3 (-/-) null mutants arrest as L3 larvae and kin-10 (-/-) 
as L4 larvae. Consequently, CK2 null mutants are maintained in a genetically balanced 
background. Since the Rup phenotype can only be assessed in animals that reach the 
L4 stage, we examined two deletion mutants of kin-10 (ok1751 and ok2031) in the 
sensitized let-7(mg279) background. Consistent with results using kin-10 RNAi, we 
observe an enhanced Rup phenotype in kin-10 (-/-) relative to the balanced kin-10 (+/-) 
siblings for both kin-10 alleles (Fig 2-1E). Importantly, these data indicate that the kin-10 
genetic mutant recapitulates the phenotypes observed by kin-10 RNAi. 
The Rupture phenotype (Rup) of let-7 family mutants can be partially suppressed 
by concurrent depletion of their mRNA targets [35,41]. Consistent with the hypothesis 
that CK2 promotes miRISC-mediated target silencing, Rup enhancement by CK2 RNAi 
in the let-7 and miR-48 mutants is suppressed by hypomorphic mutations in their 
respective targets, lin-41 and hbl-1 (Fig 2-1F,G). miR-84 also regulates vulval precursor 
cell (VPC) fate specification by attenuating the expression of its target let-60/RAS 
[42,43]. Failure to repress LET-60 activity in specific VPCs leads to vulval cell 
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misspecification and a multi-vulva phenotype (Muv) [42]. CK2 RNAi enhances Muv in a 
mild gain-of-function let-60(ga89) allele [44] (Fig 2-1H). Taken together, these data 
indicate that CK2 genetically interacts with the let-7 family of miRNAs to promote 
miRISC function in a target-dependent manner. 
 
CK2 is required for the function of lsy-6 and miR-35 family miRNAs. 
Since CK2 is broadly expressed (Fig 2-S2B), we tested whether it is required for the 
function of non-let-7 family miRNAs. The miRNA lsy-6 functions to specify the fate of 
ASEL, one of two morphologically similar, bilaterally symmetric ASE neurons (ASEL 
and ASER), which can be monitored by expression of an ASEL-specific Plim-6::gfp 
reporter [45]. Because many neurons in C. elegans are refractory to RNAi [46], we 
performed RNAi experiments in an nre-1 mutant background, which potentiates RNAi-
mediated gene silencing in neurons [47]. CK2 RNAi enhances the penetrance of ASEL 
mis-specification in the lsy-6(ot150) hypomorph [48] to the same extent as alg-1 RNAi 
(Fig 2-1I), indicating that CK2 promotes lsy-6 function. 
The miR-35 family of miRNAs (miR-35-42) is expressed during embryogenesis 
and functions redundantly to control embryonic development [49]. Deletion of miR-35-41 
leads to semi-penetrant, temperature-sensitive late embryonic lethality [49]. At the 
permissive temperature (15°C), ~10% of embryos display this phenotype, while the 
remaining 90% develop normally. Depletion of CK2 or the gene encoding the core 
miRISC factor nhl-2 significantly increases embryonic lethality, consistent with the 
requirement of CK2 for the function of the miR-35 family of miRNAs (Fig 2-1J). 
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Collectively, our results are consistent with CK2 broadly promoting miRNA function to 
mediate a range of biological processes in multiple C. elegans tissues. 
 
CK2 is required for miRNA target silencing 
Since KIN-3 and KIN-10 depletion enhances multiple miRNA mutant phenotypes, we 
sought to determine if these CK2-dependent physiological defects could be explained 
by miRNA target de-repression. We examined the endogenous, developmentally 
regulated targets of both let-7 family and lin-4 miRNAs (Fig 2-2A). In C. elegans, let-7 
triggers the rapid degradation of lin-41 mRNA at the L4-to-adult transition [50,51]. lin-41 
encodes a TRIM/RBCC family protein, homologous to human TRIM71 [52], that 
negatively regulates expression of LIN-29, a transcription factor required for adult cell 
fate specification [50]. Depletion of alg-1 leads to significant de-repression of lin-41 
mRNA compared to empty vector RNAi (Fig 2-2B). Similarly, knockdown of CK2 also 
significantly de-represses lin-41 levels by 1.5 to 2 fold (Fig 2-2B, left panel). De-
repression is also observed for the let-7 family target daf-12, which encodes a nuclear 
steroid hormone receptor that integrates environmental signals and developmental 
timing [51,53] (Fig 2-2B, right panel).  
To determine if de-repression of target mRNAs by CK2 RNAi results in elevated 
target mRNA translation, we examined endogenous protein levels of LIN-14 upon CK2 
RNAi. The early-acting heterochronic miRNA, lin-4, targets and silences lin-14 mRNA 
during the L1-to-L2 larval transition [1,54], resulting in a commensurate decrease in LIN-
14 protein. In animals fed empty vector control RNAi, the LIN-14 protein is robustly 
expressed during the L1 stage (4 hr) and dramatically decreases by the L2 stage (Fig 2-
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2C; 20 hr).  In contrast, when animals are subjected to CK2 RNAi, LIN-14 levels remain 
high during the L1 to L2 transition to a similar degree, or possibly higher, than animals 
on alg-1 RNAi (Fig 2-2C; 16-20 hr time points). The elevated LIN-14 expression is not 
due to any dramatic developmental delay caused by CK2 or alg-1 RNAi during this 
timeframe based on measurements of animal growth (Fig 2-S3).  
Next we examined miR-1-dependent silencing of mef-2, which encodes a 
muscle-specific transcription factor [55], using a 3’UTR GFP reporter driven by the 
muscle-specific myo-3 promoter (Fig 2-2D). Depletion of kin-3, kin-10, or alg-1 
significantly increases the intensity of mef-2 reporter expression compared to empty 
vector RNAi (Fig 2-2D,E). To test the miR-1 dependence of target reporter expression, 
we scrambled the two miR-1 binding sites in the mef-2 3’UTR. Consistent with a miR-1-
dependent effect, no significant difference in GFP expression was detected in the 
scrambled reporter with CK2 or alg-1 RNAi versus empty vector control (Fig 2-2D,E). 
Taken together, our genetic and target expression data indicate that CK2 promotes 
miRNA-mediated target silencing in a wide array of tissues and developmental stages.  
 
CK2 is dispensable for the expression of miRNAs and miRISC factors 
To explore where in the miRNA pathway CK2 functions, we first investigated whether 
CK2 regulates the biogenesis or stability of mature miRNAs. We performed deep 
sequencing of small RNAs in wild-type animals treated with vector, kin-3 or kin-10 RNAi 
and observe no significant differences in the global levels of mature miRNAs between 
empty vector and CK2 RNAi (Fig 2-3A, Fig 2-S4A and Table 2-S3). Furthermore, 
northern blot analysis of miR-48, miR-1, and bantam miRNA family ortholog, miR-58, in 
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wild-type and sensitized alg-1(tm369) animals confirmed that CK2 RNAi does not 
dramatically affect mature or precursor miRNA levels (Fig 2-3B, SI Appendix Fig 2-
S4B,C). We also examined if CK2 regulates the accumulation or stability of core 
miRISC proteins. We detect no difference by western blot of endogenous ALG-1, AIN-1, 
VIG-1, TSN-1, and CGH-1 levels between empty vector and CK2 RNAi (Fig 2-3C). 
Together, these data indicate that CK2 functions downstream of miRNA biogenesis and 
is not required for stability of individual miRISC factors. 
 
CK2 promotes miRISC association of mRNA targets 
Defects in miRISC target silencing could result from compromised ability to bind mature 
miRNAs or mRNA targets. To determine if CK2 is required for miRNA or target binding 
to miRISC, we performed RNA-immunoprecipitation (RIP) using a strain expressing 
GFP::ALG-1 [56] and compared relative miRNA and target mRNA binding in CK2 RNAi 
versus empty vector and gfp RNAi controls (Fig 2-3D). We observe no significant 
differences in the levels of let-7 or miR-48 associated with miRISC upon CK2 RNAi 
versus empty vector control RNAi (Fig 2-3E). Importantly, the target mRNAs of these 
miRNAs, lin-41 and daf-12, show a ~2-fold reduction in miRISC association upon CK2 
RNAi (Fig 2-3F). As expected, RNAi of gfp, which knocks down the expression of 
GFP::ALG-1, exhibited significant reduction of both miRNA and target mRNA levels (Fig 
2-3F,G). Taken together, these data indicate that CK2 promotes efficient binding of 
target mRNAs, but not mature miRNAs, to miRISC. 
 
CK2 phosphorylates miRISC cofactor CGH-1 
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Given our mass spectrometry data that CK2 physically associates with miRISC, we 
hypothesized that CK2 promotes miRISC target binding by phosphorylating one or more 
miRISC cofactors. We queried a C. elegans phospho-proteome dataset [57] and found 
peptides phosphorylated at CK2 motifs in CGH-1 and VIG-1. Since cgh-1 loss of 
function mutants display developmental phenotypes that are easy to observe and CGH-
1 has been implicated in promoting miRISC-target interactions [15], we first examined if 
CK2 physically interacts with CGH-1. Endogenous KIN-3 co-immunopurified with CGH-
1::GFP in lysates from C. elegans fed glp-1 RNAi to enrich the capture interactions in 
somatic tissues, the major sites of miRNA-mediated gene regulation (Fig 2-4A). glp-1 
encodes a C. elegans Notch family receptor [58] required for mitotic proliferation of 
germ cells and maintenance of germline stem cells [59]. glp-1 RNAi severely disrupts 
early germline development yielding adult animals that are primarily composed of 
somatic cells.  Mass spectrometry of CGH-1::GFP complexes confirmed the interaction 
of KIN-3 and additionally identified peptides corresponding to KIN-10 and the known 
CGH-1-interactor NHL-2 (SI Appendix Table S4).  
To establish if CGH-1 could be phosphorylated by CK2, we performed in vitro 
kinase assays. CK2 phosphorylates full length CGH-1 in a manner dependent on CK2 
activity, as inhibition of CK2 by addition of the CK2 inhibitor, TBB, or use of a 
catalytically dead KIN-3 (K67M) abrogates CGH-1 phosphorylation (Fig 2-4B). CGH-1 
harbors four consensus motifs (S/TXXD/E) for CK2 phosphorylation (Fig 2-4C). In vitro 
kinase assays with short CGH-1 peptides containing each putative CK2 phosphorylation 
site indicate that site 1, containing serine 2 (S2), is the predominant site phosphorylated 
by CK2 (Fig 2-4D). Phospho-mass spectrometry of immunopurified CGH-1::GFP 
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recovered peptides containing phosphorylated S2 from wild-type, but not CK2 RNAi, 
animals, suggesting that site 1 is phosphorylated in vivo in a CK2-dependent manner 
(Table 2-S4). While S2 is not located in any functionally annotated domain of CGH-1, it 
is within an N-terminal intrinsically disordered region [60] that is conserved in DDX6 (Fig 
2-S5). Intrinsically disordered regions have been hypothesized to be subject to post-
translational modifications by kinases and phosphatases, which may regulate protein 
function [25,61]. In addition, serine 2 of CGH-1 is broadly conserved in orthologous 
proteins and conservation of phosphorylation at this site is supported by large-scale 
phospho-proteomic evidence in amphibians and mammals (Gnad et al., 2011; Gnad et 
al., 2007). 
 
CK2 phosphorylation of CGH-1 promotes miRISC function 
If CK2 phosphorylation of CGH-1 at S2 is important for CGH-1 to promote miRISC 
activity, then CGH-1 phospho-defective mutants should have compromised miRISC 
function. To test this hypothesis, we generated multi-copy CGH-1::GFP transgenic lines 
with phospho-defective (S2A) and phospho-mimic (S2D/E) mutations (hereafter referred 
to as S2 variants) (Fig 2-S6). Since cgh-1 is critical in germline development and multi-
copy transgenes are commonly silenced in the C. elegans germline, we examined the 
function of the S2 variants in the sensitized let-7(mg279) background using a 
temperature sensitive cgh-1 point mutant, cgh-1(tn691), which phenocopies cgh-1 loss-
of-function at the non-permissive temperature of 25°C [62]. Alone, cgh-1(tn691); let-
7(mg279) displays a partially penetrant protruding vulva phenotype (Pvul) that is 
significantly rescued by wild-type CGH-1::GFP expression but significantly exacerbated 
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by the phospho-defective S2A mutation (Fig 2-4E,F). Phospho-mimics yielded less 
conclusive data: S2D mutants have a phenotype similar to the non-transgenic control, 
while S2E mutants show partial, but significant, rescue. We also examined the effect of 
the S2 variants on the retarded alae phenotype of cgh-1(tn691); let-7(mg279) mutants. 
Expression of wild-type and S2E CGH-1::GFP significantly rescue alae defects, while 
the phospho-defective S2A mutants and the S2D mutant have defects similar to, or 
greater than, the non-transgenic control (Fig 2-4G). Thus, in two different tissues, the 
CGH-1 phospho-defective S2A mutation fails to complement miRNA mutant 
phenotypes. Based on the robust phenotype of the S2A mutants, we hypothesize that 
differential results with S2D and S2E may be attributed to incomplete phospho-mimicry 
by the substituted amino acids. Together, these data support the hypothesis that 
phosphorylation at S2 is important for miRNA-dependent CGH-1 function.  
To determine the requirement for CK2 and phosphorylation of CGH-1 in a 
biological context where miRNA activity is modulated, we compared continuous 
development to post-dauer development. Continuous development from L1 to adulthood 
occurs in favorable environmental conditions. By contrast, adverse conditions promote 
entry into the stress-resistant and developmentally arrested dauer larva stage 
immediately after the L2 molt [63]. If dauer larvae encounter an environment suitable for 
growth, they resume normal development such that post-dauer cell divisions are 
identical to those occurring during continuous development [64,65]. Robustness to 
developmental interruption by dauer is due, in part, to enhanced activity of lin-4 and let-
7 family miRNAs, such that lin-4 can substitute for miR-48, miR-241, and miR-84 during 
post-dauer development but not continuous development [66]. Surprisingly, 
 52 
enhancement of miRNA activity occurs without alg-1, as heterochronic phenotypes of 
alg-1 mutants are efficiently suppressed post-dauer [66]. This suggests that modulatory 
proteins elevate the activity of the remaining ALG-2-containing miRISC. CK2 appears to 
contribute to this phenomenon, as kin-3 RNAi significantly reduces post-dauer 
suppression of alg-1(gk214) alae defects (Fig 2-S7A). Interestingly, we observe that 
during post-dauer development, the retarded alae phenotype of S2A mutants is 
significantly suppressed, suggesting that CK2 modification of CGH-1 is dispensable 
during post-dauer development (Fig 2-S7B). 
 
DISCUSSION  
Here we report that subunits encoding the C. elegans casein kinase II, kin-3 and kin-10, 
are required for effective activity of the miRNA pathway. Genetically, our analyses 
suggest that kin-3 and kin-10 promote the function of several miRNA/miRNA families 
that regulate diverse processes, including the conserved function of the let-7 family of 
miRNAs in the control of animal development and cellular differentiation. 
Mechanistically, our analyses place CK2 function at the step of miRISC association with 
mRNA targets, downstream of miRNA biogenesis and loading into miRISC. Molecular 
assays indicate that CK2 subunits are required for target silencing and that their 
depletion compromises miRISC binding to let-7 target mRNAs. Through the use of 
proteomic and in vitro methods we establish conserved miRISC cofactor, CGH-1, as a 
direct CK2 substrate at a conserved N-terminal serine residue (S2). Additional genetic 
analyses suggest that S2 is important for miRNA-dependent CGH-1 function in the let-7 
pathway. Since CGH-1 is part of a family of DEAD-box helicases that influence all 
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permutations of protein-protein, protein-RNA and RNA-RNA interactions, we propose 
that phosphorylation of CGH-1 by CK2 may influence miRISC target binding by (1) 
directly promoting miRISC interaction with targets, either by promoting CGH-1 
association with miRISC, or by altering affinity of a CGH-1 associated-miRISC for 
targets, and/or (2) promoting CGH-1 association with factors involved with mRNA 
translation and decay. Biochemically, phosphorylation in the N-terminal disordered 
region of CGH-1 may affect these changes by triggering a conformational change that 
alters the intrinsic activity of CGH-1 or facilitates its association with other factors. 
Intriguingly, our analysis of post-dauer development suggests that CK2 function in the 
C. elegans miRNA pathway is different than during continuous development. Post-dauer 
suppression of miRNA phenotypes requires CK2, but not CK2 phosphorylation of CGH-
1 (Fig 2-S7B), suggesting that during post-dauer development, CK2 may have 
alternative miRNA pathway substrates. Alternatively, additional factors may dictate CK2 
specificity during continuous development versus post-dauer development. Despite 
considerable efforts, the matter of whether CK2 is constitutively active or activated by 
specific signals remains controversial [67]. Therefore further investigation into CK2 
function in the miRNA pathway during post-dauer development in may prove a useful 
system for extending our understanding of the regulation of CK2. As modulating miRNA 
activity is crucial for development and disease, dissecting the mechanisms that activate 
or antagonize CK2 activity in the miRNA pathway may also provide further insights into 
how the miRNA pathway is regulated. 
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MATERIALS AND METHODS  
 
Detailed methods are available in Supplemental materials and methods.   
 
C. elegans strains and plasmids. All strains used in this study are listed in Table 2-S1. 
C. elegans were grown and maintained under standard laboratory conditions [68] and 
synchronized by hypochlorite treatment and overnight hatching in M9 buffer, except 
where indicated. Descriptions of plasmid construction and generation of transgenic 
animals are described in Supplemental Methods. 
 
RNAi. All RNAi clones are from the Ahringer RNAi library [69], except the kin-3 RNAi 
clone, which is from the C. elegans ORFeome RNAi library [70], and the cgh-1 3’UTR 
RNAi clone (pJK301), which was made for this study. Standard RNAi procedures [71] 
were followed. Specific modifications to RNAi conditions, including duration, strength, 
and temperature, are detailed in Supplemental Methods. 
 
mef-2 reporter intensity. Images were captured on an Olympus BX61 epifluorescence 
compound microscope with a Hamamatsu ORCA ER camera using Slidebook 4.0.1 
digital microscopy software (Intelligent Imaging Innovations) and processed in ImageJ 
with custom scripts. 
 
Dauer induction and post-dauer phenotyping. Dauer Induction was achieved using 
crude dauer pheromone (Vowels and Thomas, 1994) for kin-3(RNAi) experiments and 
by starvation/crowding for experiments with cgh-1(tn691); let-7(mg279). All strains were 
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maintained at 20°C. Strains in the cgh-1(tn691); let-7(mg279) background were shifted 
to 25°C at the L2 molt during continuous development or after selection of dauer larvae 
for post-dauer development . Additional phenotyping details are provided in 
Supplemental Methods.  
 
CK2 in vitro kinase assays. Recombinant GST fusion proteins were generated and 
isolated from E.coli according to [72]. Purified recombinant proteins were analyzed by 
SDS-PAGE and Coomassie Blue to determine protein concentrations by comparison to 
BSA standards. For in vitro kinase reactions, 1 µg of recombinant CGH-1 was mixed 
with 500 nM recombinant KIN-3 (either WT or K67M mutant), 500 nM KIN-10, 4 µCi of 
P32 γATP, and 200 µM cold ATP in 20 mM Tris-HCl, pH7.5, 50 mM KCl, and 20 mM 
MgCl2. Reactions were incubated at room temperature for 30 min. To inhibit CK2 
activity in vitro, TBB (4,5,6,7-tetrabromobenzotriazole) was added to 5 µM. To map the 
specific phosphorylation site on CGH-1: GST-tagged CGH-1 peptides comprised of the 
20aa flanking the four putative CK2 phosphorylation sites were incubated with CK2 as 
described above (peptide sequences in Table 2-S2). All data were analyzed by SDS-
PAGE and autoradiography.  
 
Western blotting. Protein samples from synchronized populations were prepared by 
direct boiling in Novex Tris-Glycine SDS sample buffer (Invitrogen), supplemented with 
0.1 M DTT, resolved on Novex Tris-Glycine gels (Invitrogen), and immobilized on 
Immobilon-FL transfer membrane (Millipore). Membranes were probed with custom 
rabbit polyclonal antibodies to ALG-1 (1:1000), AIN-1 (1:1000), CGH-1 (1:1000), GFP 
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(1:500), KIN-3 (1:500), TSN-1 (1:1000) and VIG-1 (1:1000), or γ-tubulin (Sigma LL-17) 
(1:2000). Peroxidase-AffiniPure goat anti-rabbit IgG secondary antibody was used at 
1:10000 (Jackson ImmunoResearch Laboratories) for detection using Pierce ECL 
western Blotting Substrate (Thermo Scientific).  
 
Antibody production. Custom polyclonal antibodies to C. elegans proteins were 
generated by immunizing rabbits with synthetic antigenic peptides conjugated to KLH 
(Proteintech). Antigenic peptide sequences are listed in Table 2-S2. Antibody to GFP 
was made using recombinant GFP purified from E. coli. The LIN-14 antibody was a gift 
from Gary Ruvkun [73].  
 
Immunoprecipitation and mass spectrometry. Synchronized populations were frozen 
in liquid nitrogen and homogenized with a Mixer Mill MM 400 ball mill homogenizer 
(Retsch). Immunoprecipitations from homogenates were performed using guidelines 
described [74], with additional details provided in Supplemental Methods. Protein 
identification by mass spectrometry was performed as described [75]. 
 
RNA analyses. Samples were collected from synchronized populations at the following 
times: 48 hr post-L1 for mature miRNA, 44 hr post L1 for lin-41 mRNA, 40 hr post L1 
daf-12 mRNA. Conditions for kin-3, kin-10, and alg-1 RNAi are described in the RNAi 
methods. Total RNA isolation was conducted as described [76] For miRNA analysis: (1) 
Northern blotting was performed as described [77] using 1.5 µg total RNA and Starfire 
DNA probes (IDT) (Table 2-S2), (2) RT-qPCR analysis was conducted using miRNA 
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TaqMan assays and probes (hsa-let-7a cat#4427975, cel-miR-28 cat#4427975, U18 
cat#4427975) (Applied Biosystems) as described [76] . For mRNA analysis cDNA was 
synthesized from total RNA using the Multiscribe Reverse Transcriptase Kit (Applied 
Biosystems). Specific mRNAs were analyzed by RT-qPCR using Power SYBR Green 
Master Mix 2X (Applied Biosystems). Relative miRNA and mRNA levels were calculated 
based on the ΔΔ2Ct method [78] using U18 and eft-2 for normalization, respectively. 
RT-qPCR primer sequences and Starfire Probes are listed in Table 2-S2. 
 
RNA-Immunoprecipitation (RIP). GFP-ALG-1 was immunoprecipitated from L4 stage 
(48 hr post L1) CT20 with 3E6 anti-GFP antibody (Invitrogen). For each RIP, antibody 
was cross-linked to Protein A Dynabeads (Invitrogen) and incubated at 4°C for 1 hr with 
homogenized sample. Beads were washed with RIP wash buffer (50 mM Tris-HCl pH 
7.5, 200 mM KCl, 0.05% NP-40), then split for protein and RNA analyses. For protein 
analyses, SDS sample buffer (Novex Tris-Glycine, Invitrogen), was added directly to 
beads and incubated at 50°C for 10 min. Eluted proteins were supplemented with 0.1 M 
DTT, and incubated at 90°C for 5 min prior to western blotting. For RNA analysis, 1 ml 
of TRI-Reagent (Ambion) and 10 ng of Firefly Luciferase RNA (Promega) was directly 
added to beads and extracted as described in RNA Analyses, with extended RNA 
precipitation for 2 hr at -30°C. cDNA and miRNA taqmans were synthesized and 
analyzed as described in RNA Analyses. RT-qPCR analyses were normalized to firefly 
luciferase.  
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Small RNA sequencing and miRNA analysis. Samples were collected from 
synchronized populations of 48 hr post-arrested L1 fed L4440, kin-3, or kin-10 RNAi. 
Total RNA was isolated as described in “RNA Analyses” section. Total RNA was 
submitted to the Beijing Genomics Institute for deep sequencing. Sequencing reads 
were processed to remove low quality reads and trim artificial adapter sequences 
following BGI protocols. Briefly, reads were marked and removed for low quality if they 
had (1) more than 4 bases whose quality score was lower than 10 or (2) more than 6 
bases whose quality score was lower than 13. 3’ adapter sequences were then trimmed 
from the remaining high-quality reads. Finally, reads were removed if they (1) lacked a 
3’ adapter sequence, (2) were 5’-3’ adapter ligation products, (3) were 5’-5’ adapter 
ligation products, (4) were shorter than 18 nt, or (5) contained only As (homopolymers). 
High-quality reads were aligned to the reference C. elegans genome version WS220 
using Bowtie2 [79] with the following parameters: -f -N 0 -M 10. Reads that aligned with 
zero mismatches to one genomic locus were annotated to mature miRNA coordinates 
from miRBase Release 19 [4]. Mature miRNA read counts in each library were 
normalized to the number of mapped reads in the library; mature miRNA abundance is 
reported as reads per million mapped reads (RPM) (Table 2-S3). Raw sequence data 
are available through the NCBI’s Gene Expression Omnibus using accession 
GSE66764. 
 
SUPPLEMENTAL MATERIALS AND METHODS 
Plasmids and Transgenic Strains. The kin-3::gfp reporter plasmid (pJK194) was 
generated by introducing the following fragments into pJK211 (a derivation of Fire 
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vector pPD49.26): kin-3 endogenous promoter (2.0 kb fragment immediately upstream 
of the kin-3 start codon), kin-3 genomic coding region (2.2 kb fragment with mutated 
termination codon), gfp coding region (0.9 kb fragment with synthetic introns and 
termination codon), and kin-3 endogenous 3′UTR (1.2 kb fragment immediately 
downstream of kin-3 termination codon). The Pmef-2::gfp::mef-2 3’UTR reporter 
KP#1438 was generated by sub-cloning the following fragments into gfp 3’UTR reporter 
KP#1436 [55]: mef-2 endogenous promoter (4.1kb fragment upstream of the mef-2 
coding region) and mef-2 endogenous 3′UTR (2.2kb fragment downstream of mef-2 
termination codon). The two most 5’ miR-1 sites in the mef-2 3’UTR were scrambled to 
abrogate seed recognition using SOE-PCR and subcloned into KP#1438 to create the 
Pmef-2::gfp::mef-2 3’UTR (scrambled miR-1 sites I and II) plasmid. The cgh-1::gfp 
reporter plasmid (pJK297) was generated by introducing the following fragments into 
pJK211: cgh-1 endogenous promoter and genomic coding region (~3.7 kb fragment 
including 2.1 kb immediately upstream of the cgh-1 start codon and the cgh-1 coding 
region with mutated termination codon), gfp coding region (0.9 kb fragment with 
synthetic introns and termination codon), and unc-54 3’UTR (0.76 kb PCR fragment 
downstream of the unc-54 termination codon which includes the 282 bp annotated unc-
54 3’UTR. cgh-1::gfp S2 variants were generated from pJK297 by introducing site-
specific mutations to alter serine to encode alanine (pJK789), aspartic acid (pJK787), or 
glutamic acid (pJK791) Reporter plasmids were used to generate multi-copy integrated 
transgenes as described [80].  
The cgh-1 3’UTR RNAi clone (pJK301), which was made by subcloning a ~0.5 kb 
fragment amplified from the cgh-1 3’UTR into the vector, L4440 [Primer I: 
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ACACTAGTTCTCATATCCCCAAACCTCCAAAACACACAGCGGCCGCCATATCCCCA
AACCTCCAAAACAC (Not-I); Primer 2: 
AATGTGGTGCGGCTCAACAGAATAACTACAAATGCTAGCCGGCTCAACAGAATAAC
TACA (Nhe I)] , followed by transformation into E. coli HT115. 
 
Modified RNAi Conditions. Since several genes in this study are essential for 
development and/or fertility, feeding RNAi (1) duration (one versus two generations) and 
(2) strength (RNAi cultures were diluted with cultures from bacteria expressing the 
empty vector L4440) were optimized to achieve a balance of efficient knockdown and 
viability. For RNAi spanning two generations, two rounds of synchronization were 
performed. RNAi conditions for alae defect, seam cell number, adult collagen 
expression, lethargus, Rup, and Muv assays were as follows: kin-3 RNAi (1 generation, 
no dilution), kin-10 RNAi (2 generations, 1:1 dilution), alg-1 RNAi (1 generation, 1:1 
dilution), ain-1 RNAi (2 generations, no dilution), and nhl-2 RNAi (2 generations, no 
dilution). RNAi for mef-2 GFP reporters were for two generations as follows, images of 
young adults were taken in the second generation: kin-3 RNAi (P0 1:2 dilution, F1 1:1 
dilution), kin-10 RNAi (P0 and F1 1:1 dilution), alg-1 RNAi (P0 vector, F1 1:1 dilution), 
and both gfp and vector RNAi (P0 and F1 no dilution). RNAi for LIN-14 western analysis 
was as follows: kin-3 RNAi (1 generation, 1:2 dilution), kin-10 RNAi (1 generation, 1:1 
dilution), alg-1 RNAi (2 generations: P0 at 1:2 and F1 at 1:1), and lin-14 RNAi (1 
generation, 1:1 dilution). Additional modifications to the standard feeding protocol 
include: (1) assays with QK005 were grown on vector RNAi for 36 hr, then transferred to 
undiluted RNAi for 120 hr prior to scoring ASEL neuron specification, (2) assays with 
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MT14119 were grown on vector RNAi until the L3 larval stage, then transferred to 
undiluted RNAi; adults were removed post-egg lay and their eggs scored for viability. 
Temperature modifications include: QK005, SD551, and QK039-QK044 were grown at 
25°C. MT14119 was grown at 15°C. 
 
Dauer Induction and Post-Dauer Phenotyping. For kin-3 RNAi experiments alg-
1(gk214) embryos isolated by alkaline-hypochlorite embryo extraction were plated 
directly on RNAi at 20˚C. For continuous development, animals were grown for 2-3 days 
to reach young adult stage. For post-dauer development post-dauer development, 
animals were grown on RNAi plates with crude dauer pheromone [81] in parallel to 
animals in continuous development. After 2-3 days, dauer were picked by morphology 
to fresh RNAi plates lacking pheromone. These post-dauer larvae were grown for an 
additional day to reach young adult stage. For comparison between continuous 
development and post-dauer development in QK039-QK044, strains were maintained at 
20˚C. For continuous development, a synchronized population was obtained by an adult 
egg lay for 3-4 hrs at 20˚C. Adults were removed and progeny were kept at 20˚C for ~30 
hrs (until the L2 molt). Larvae were then shifted to 25˚C where they grew for another 40-
45 hrs (~24 hrs past L4 molt). For post-dauer development, dauers were selected from 
populations starved at 20˚C by treatment in 1% SDS for 20 minutes. Dauers were then 
grown on fresh plates at 25˚C for 48 hrs (~24 hrs past the L4 molt). For analysis of 
continuous development only QK039-QK044 were kept at 25˚C from adult egg lay.  In 
all cases, each individual was categorized as having either no adult alae, gapped adult 
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alae, or complete adult alae. One side was scored per individual using DIC optics on a 
Zeiss AxioImager D2 compound microscope.  
 
Immunoprecipitation. The following adaptations of [74] were used to perform 
immunoprecipitations for mass spectrometry: C. elegans homogenates were suspended 
in lysis buffer (50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM MgCl2, 100 mM KCl, 10% 
glycerol, 0.05% NP-40 supplemented with Complete, Mini, EDTA-free Protease Inhibitor 
Cocktail tablet (Roche Applied Sciences), and clarified by centrifugation at 12,000X g 
for 12 min at 4°C. For immunoprecipitations, primary antibody conjugated to Dynabeads 
Protein A (Invitrogen) was incubated with homogenates at 4°C for 4 hr, then washed 
three times with wash buffer (50 mM HEPES pH 7.4, 1 mM EGTA, 1 mM MgCl2, 300 
mM KCl, 10% glycerol, 0.05% NP-40 supplemented with Complete, Mini, EDTA-free 
Protease Inhibitor Cocktail tablet (Roche Applied Sciences). Immunoprecipitated 
proteins were eluted from beads with three aliquots of 150 µL of 0.1 M glycine, pH 2.6. 
Eluates were neutralized with 150 µL of 2M Tris-HCl, pH 8.5, combined with 1/5 volume 
of 100% trichloroacetic acid, and precipitated overnight at 4°C. Proteins were pelleted 
by centrifugation at 20,000X g for 30 min and washed twice with acetone.  
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Figure 2-1. CK2 genetically interacts with the miRNA pathway. (A-B) CK2 depletion 
results in phenotypes associated with reduced miRNA pathway function: (A) RNAi of 
kin-3, kin-10, or alg-1 significantly increases defective alae versus empty vector control 
(two-tailed Fisher’s exact test p<0.0001). (B) RNAi of kin-3, kin-10, nhl-2, alg-1, and ain-
1 in animals expressing a seam cell gfp reporter (Pscm::gfp) all exhibit significant seam 
cell hyperplasia post L4 versus empty vector control (asterisk: two-tailed Student’s t-test 
p<0.001, mean and standard deviation (SD) plotted, n=50). (C-J) CK2 depletion 
enhances miRNA mutant defects: (C) RNAi of kin-3, kin-10, nhl-2, alg-1, and ain-1 all 
exhibit significant enhancement of adult animals in lethargus versus empty vector 
control (asterisk: two-tailed Student’s t-test of biological replicates p<0.05, mean and SD 
plotted, n≥50 per replicate). Adult animals inappropriately entering lethargus were 
scored every 2h from 60 hr to 72 hr post L1. (D) kin-3 and kin-10 RNAi enhance Rup of 
let-7, let-7 family, and miRISC factor mutants at 72 hr post L1, 20°C. Heatmap 
represents mean percent Rup of biological replicates (n≥50 per replicate). (E) Rup in 
homozygous kin-10 deletion mutants is significantly greater than hT2[qIs48] balanced 
kin-10/+ siblings (two-tailed Fisher’s exact test p≤0.003). (F-G) kin-3 and kin-10 RNAi 
Rup enhancement in let-7 and mir-48 mutants is dependent on their targets: (F) Rup 
enhancement of kin-3 and kin-10 RNAi in let-7(mg279) is decreased in the lin-
41(ma104) background (mean and SD of biological replicates plotted, n≥37 per 
replicate). (G) Rup enhancement of kin-3 and kin-10 RNAi in mir-48(n4097) is 
decreased in the hbl-1(mg285) background (mean and SD of biological replicates, n≥56 
per replicate). (H) RNAi of kin-3, kin-10, nhl-2, and alg-1 all significantly enhance Muv 
versus empty vector control (asterisk: two-tailed Student’s t-test of biological replicates 
p<0.05, mean and SD plotted, n≥94 per replicate). (I) kin-3 and kin-10 RNAi increase 
the penetrance of ASEL misspecification in neuronal RNAi-competent lsy-6(ot150) 
strain indicated by the lack of Plim-6::gfp expression in ASEL (Fisher’s exact test 
p<0.0001 for kin-3 and alg-1 RNAi, p=0.0002 for kin-10 RNAi) (J) kin-3 and kin-10 RNAi 
enhance embryonic lethality in mir-35-41(nDf50) (asterisk: two-tailed Fisher’s exact test 
p<0.001, n≥145).  
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Figure 2-2. CK2 is required for miRNA target silencing. (A) Abridged table of 
miRNAs and their target mRNAs examined in this study. (B) kin-3 and kin-10 RNAi 
attenuate silencing of let-7 family targets lin-41 and daf-12: lin-41 mRNA levels are 
significantly elevated in kin-3 and kin-10 RNAi versus vector RNAi (44 hr post L1, 20°C) 
(left panel); daf-12 mRNA levels are substantially elevated in kin-3 and kin-10 RNAi 
versus vector RNAi (40 hr post L1, 20°C) (right panel). (asterisk: one-tailed Student’s t-
test of biological replicates p<0.050, mean and SD plotted). (C) kin-3 and kin-10 RNAi 
attenuates silencing of lin-4 target lin-14. LIN-14 is up-regulated in kin-3 and kin-10 
RNAi versus empty vector control in L2 (16 hr to 20 hr post L1). γ-tubulin used as a 
loading control. (D-E) kin-3 and kin-10 RNAi attenuate silencing of miR-1 target mef-2 in 
a miR-1-dependent manner. (D) Reporter constructs shown with wild-type and 
scrambled miR-1 sites (left). Arrows indicate vulva in representative images (right). (E) 
mef-2 reporter quantification. RNAi of kin-3, kin-10 and alg-1 all significantly increase 
GFP signal of the wild-type reporter versus vector (p<0.05, mean and SD plotted, 
n>10), but not the scrambled reporter (p≥0.60). 
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Figure 2-3. CK2 promotes miRISC target binding. (A-B) CK2 does not affect miRNA 
levels: (A) kin-3 RNAi does not affect global mature miRNA abundances as quantified 
by deep sequencing (reads per million mapped reads: RPM). (B) Global analysis in (A) 
is supported by northern blotting: kin-3 and kin-10 RNAi do not substantially alter levels 
of precursor or mature miR-48 in wild-type or alg-1(tm369) animals. (C) CK2 RNAi does 
not considerably affect miRISC factor levels. Western analysis of core miRISC proteins 
in kin-3 and kin-10 RNAi are similar to empty vector control. (D-F) CK2 affects miRISC 
binding to target mRNAs: (D) Schematic and western analysis of GFP::ALG-1 RNA 
immunoprecipitation (RIP) from L4 (48 hr post L1, 20°C) lysates of empty vector versus 
kin-3 and kin-10 RNAi; gfp RNAi controls for RIP; γ-tubulin controls for protein input. (E) 
Levels of let-7 and miR-48 associated with GFP::ALG-1 are not significantly different in 
kin-3 and kin-10 RNAi versus empty vector. (F) Levels of lin-41 and daf-12 mRNA 
associated with GFP::ALG-1 are decreased in kin-3 and kin-10 RNAi versus empty 
vector. RIP RNAs were normalized to spiked-in firefly luciferase mRNA (asterisk: one-
tailed Student’s t-test of biological replicates p<0.05, mean and SD plotted). 
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Figure 2-4. CK2 phosphorylates miRISC factor CGH-1 at serine 2. (A) KIN-3 
associates with CGH-1 in the soma. CK2 catalytic subunit, KIN-3, co-immunopurifies 
with CGH-1::GFP in animals fed glp-1 RNAi to prevent germline proliferation. (B) CGH-1 
is phosphorylated by CK2 in vitro. Autoradiogram of GST-purified wild-type CGH-1 
incubated with GST-purified CK2 comprised of wild-type or ATP-binding site mutant 
KIN-3 (K67M). TBB: CK2 inhibitor (4,5,6,7-tetrabromobenzotriazole). (C) CGH-1 
harbors four CK2 recognition motifs (sites 1-4). (D) Site 1 (serine 2) is phosphorylated 
by CK2 in vitro. GST-tagged CGH-1 peptides comprised of 20 residues flanking each 
putative CK2 phosphorylation site were incubated in vitro with CK2 and analyzed by 
SDS-PAGE and autoradiography. 32P: autoradiogram. CB: Coomassie Blue stained gel. 
(E-F) Genetic analysis of CGH-1 serine 2 (S2) phospho-variants in cgh-1(tn691)ts; let-
7(mg279) suggests phosphorylation of CGH-1 at S2 promotes miRISC function (E) 
Representative images of Protruding vulva (Pvul). Adult vulva indicated by arrow (120 
hr post-L1, 25°C). (F) Quantitation of Pvul. Compared to cgh-1(tn691)ts;let-7(mg279) 
with no transgene the cgh-1:gfp (S2) transgene significantly rescues Pvul. S2A mutants 
(Lines 1 and 2) significantly enhance Pvul (asterisk: two-tailed Fisher’s exact test 
p<0.0001 for S2 variants versus “No TG”, mean and SD plotted for three technical 
replicates within a single experiment, n≥95). (G) S2 and S2E significantly rescue alae 
defects of cgh-1(tn691)ts;let-7(mg279). S2A mutants significantly enhance (Line 1) or 
have no significant effect (Line 2) on defects (asterisk: two-tailed Fisher’s exact test 
p<0.0001 for S2 variants versus “No TG”). TG: transgene; S2A Lines 1 and 2: phospho-
defective Ser-to-Ala mutation; S2D/E: phospho-mimic Ser-to-Asp/Glu mutations. 
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Figure 2-S1. RNAi efficiently knocks down CK2. (A) kin-10 mRNA is efficiently 
depleted by kin-10 RNAi at L3 (F1 RNAi, 1:1 dilution with vector) and young adult (P0 
RNAi, full strength). (B) KIN-3 protein is efficiently depleted in late L4-young adult by 
kin-3 RNAi (P0 RNAi, 1:1 dilution with vector).  
  
2.0
Figure S1
re
lat
ive
 ki
n-
10
 m
RN
A 
0.0
0.5
1.0
1.5
L3 YAd
vector RNAi
 kin-10 RNAi
A
KIN-3
vector kin-3
RNAi
B
-Tub
 73 
Figure 2-S2. kin-3 and kin-10 RNAi cause retarded defects in miRNA-mediated 
adult hypodermal remodeling.  (A) kin-3 and kin-10 RNAi delay expression of adult-
specific Pcol-19::gfp reporter. GFP expression was substantially decreased in 
populations fed kin-3 and kin-10 RNAi versus vector at time points spanning young 
adult through second day gravid (60 hr, 72 hr and 84 hr post L1 at 20°C). Mean and 
standard deviation of biological replicates are plotted (n>50 each). (B) KIN-3 is broadly 
expressed in larval animals. Top panels: Fluorescence microscopy of KIN-3::GFP 
driven by a 2 kb kin-3 endogenous promoter. Bottom panels: DIC. 
 
 
  
Figure S2
KIN-3::GFP
20um
KIN-3::GFPKIN-3::GFP KIN-3::GFP
50um 20um
B
0
5
10
15
20
25
30
35
40
vec
tor
kin
-3 
kin
-10
 
nh
l-2
alg
-1
ain
-1
%
 a
nim
als
 w
ith
 re
du
ce
d
Pc
ol
19
::G
FP
RNAi:
0
10
20
30
40
50
60
70
vec
tor
kin
-3 
kin
-10
 
nh
l-2
alg
-1
ain
-1
0
10
20
30
40
50
60
70
80
vec
tor
kin
-3 
kin
-10
 
nh
l-2
alg
-1
ain
-1
A
60
72
80
hours post L1(20$C)
t-test not signi!cant   - could do chi test but would have to sum replicates 
or only show one - which means no eror bars could be shown
Figure S2
KIN-3::GFP
20um
KIN-3::GFPKIN-3::GFP KIN-3::GFP
50um 20um
B
0
5
10
15
20
25
30
35
40
vec
tor
kin
-3 
kin
-10
 
nh
l-2
alg
-1
ain
-1
%
 a
nim
als
 w
ith
 re
du
ce
d
Pc
ol
19
::G
FP
RNAi:
0
10
20
30
40
50
60
70
vec
tor
kin
-3 
kin
-10
 
nh
l-2
alg
-1
ain
-1
0
10
20
30
40
50
60
70
80
vec
tor
kin
-3 
kin
-10
 
nh
l-2
alg
-1
ain
-1
A
60
72
80
hours post L1(20$C)
t-test not signi!cant   - could do chi test but would have to sum replicates 
or only show one - which means no eror bars could be shown
 74 
Figure 2-S3. RNAi treatments do not cause substantial developmental delay by L2 
stage. Representative images of larvae used in LIN-14 western Analysis taken at the 
same magnification. Substantial growth observed between 8 hr and 20 hr suggests a 
lack of RNAi-induced developmental delay.  
  
Figure S4
kin-3
kin-10
alg-1
lin-14
vector
RNAi:
8hr 20hr
time post-starved  L1A
 75 
Figure 2-S4. CK2 does not affect miRNA levels. (A) kin-10 RNAi does not affect 
global miRNA abundance. Mature miRNA levels are quantified by deep sequencing and 
represented as number of reads mapping to each mature miRNA normalized to total 
mapped library size in millions (RPM). (B) Global analysis in (A) was confirmed by 
northern blotting: kin-3 and kin-10 RNAi do not alter levels of precursor or mature miR-1 
or miR-58 in wild-type or alg-1(tm369).  
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Figure 2-S5. CGH-1 and DDX6 have N-terminal intrinsically disordered regions 
that contain S2. Amino acid sequence of (A) CGH-1 and (B) DDX are plotted on the x-
axis.  Regions of the protein above the dotted line, highlighted in orange, are predicted 
to be intrinsically disordered. S2 is marked with a blue asterisk. 
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Figure 2-S6. Relative CGH-1::GFP expression of S2 variants. CGH-1::GFP 
expression was determined by SDS-PAGE and western blotting lysates of young adults 
(52 hr 20°C) using antibodies against GFP and endogenous CGH-1. γ-Tubulin loading 
control. (A) Soma-enriched expression of wild-type and S2 variant CGH-1::GFP 
expressing strains. glp-1 RNAi was used to deplete germline. Two exposures of the 
anti-CGH-1 western blot are shown to best illustrate expression of either CGH-1::GFP 
(exposure 1) or endogenous CGH-1 (exposure 2). (B) Expression of CGH-1::GFP. Band 
specificity demonstrated in S2 fed cgh-1 RNAi [Lane 1] or gfp RNAi [Lane 2], to 
knockdown endogenous cgh-1 or both the cgh-1::gfp transgene and endogenous cgh-1, 
respectively, compared to no RNAi treatment [Lane 3]. Wild-type CGH-1::GFP = S2. 
Phospho-defective CGH-1::GFP= S2A Lines 1 and 2. Phospho-mimic CGH-1::GFP= 
S2D and S2E. 
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Figure 2-S7. Post-dauer suppression of miRNA phenotypes requires KIN-3, but 
not CK2 phosphorylation of CGH-1. (A) KIN-3 is required for post-dauer suppression 
of alg-1(gk214) alae defects. alg-1(gk214) on vector RNAi significantly suppress alae 
defects in post-dauer development (PDD). kin-3 RNAi abrogates suppression of 
defective alae phenotypes in PDD (significance determined by two-tailed Student’s t-
test of biological replicates, mean and standard deviation are plotted, n≥39 per 
replicate). (B) Phosphorylation of CGH-1 is required only during continuous 
development (CD), and not during post-dauer development (PDD). Strains were grown 
at the permissive temperature until the L2 molt (for CD) or dauer (for PDD) (see 
Methods). Asterisk indicates p<0.0001 by two-tailed Fisher’s exact test, n>60, each 
experiment was carried out at least twice. For all: TG= transgene, S2A Lines 1 and 2 = 
phospho-defective, S2D/E = phospho-mimic.  
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Table 2-S1. C. elegans strains used in this study. 
 
  
Table S1
Strain ID Genotype Source
N2 C. elegans wild isolate; wild-type reference strain (WT) CGC*
MH2385 ain-1(ku322) X CGC
QK051 ain-1(tm3681) X NBRP**
GS5217 alg-1(gk214) X IS Greenwald
QK045 alg-1(tm369) X NBRP
QK039 cgh-1(tn691) III; let-7(mg279) X this study
QK040 cgh-1(tn691) III; let-7(mg279) X; xkIs26 [Pcgh-1::cgh-1(WT)::GFP::unc-54 3'UTR] this study
QK041 cgh-1(tn691) III; let-7(mg279) X; xkIs27 [Pcgh-1::cgh-1(S2A)::GFP::unc-54 3'UTR] this study
QK042 cgh-1(tn691) III; let-7(mg279) X; xkIs28 [Pcgh-1::cgh-1(S2A)::GFP::unc-54 3'UTR] this study
QK043 cgh-1(tn691) III; let-7(mg279) X; xkIs29 [Pcgh-1::cgh-1(S2D)::GFP::unc-54 3'UTR] this study
QK044 cgh-1(tn691) III; let-7(mg279) X; xkIs30 [Pcgh-1::cgh-1(S2E)::GFP::unc-54 3'UTR] this study
QK032 eri-1(mg366) IV; mir-48(n4097) V this study
CT11 hbl-1(mg285) X CGC
RG365 him-1(e879) I; veIs13[col-19::gfp; rol-6(su1006)] V AE Rougvie
VC1280 kin-10(ok1751) I/hT2 [bli-4(e937) let-?(q782) qIs48](I;III) CGC
VC1609 kin-10(ok2031) I/hT2 [bli-4(e937) let-?(q782) qIs48](I;III) CGC
GR1432 let-7(mg279) X CGC
MT7626 let-7(n2853) X CGC
SD551 let-60(ga89) IV CGC
CT8 lin-41(ma104) I CGC
QK004 lin-41(ma104) I; let-7(mg279) X this study
MT14119 mir-35-41(nDf50) II CGC
MT13650 mir-48(n4097) V CGC
QK003 mir-48(n4097) V; hbl-1(mg285) X this study
MT13652 mir-48 (n4097) V; mir-84(n4037) X CGC
MT13651 mir-84(n4037) X CGC
OH3646 otIs114 [Plim-6::gfp] I; lsy-6(ot150) V CGC
QK005 otIs114 [Plim-6::gfp] I; lsy-6(ot150) V; nre-1(hd20) lin-15b(hd126) X this study
VH624 rhIs13 [unc-119::gfp, dpy-20(+)] V; nre-1(hd20) lin-15b(hd126) X CGC
JR672 wIs54[scm::gfp] V JH Rothman
QK006 xkIs25 [Pkin-3::kin-3::GFP::kin-3 3'UTR] this study
QK052 xkIs31 [Pmyo3::gfp::mef-2 3'UTR] this study
QK053 xkEx9 [Pmyo-3::gfp::mef-2 3UTR (scrambled miR-1 sites I and II)] this study
CT20 zaIs5 [alg-1P::GFP::alg-1 + pRF4(rol-6(su1006))] CGC
*CGC - Caenorhabditis Genetics Center, University of Minnesota, Minneapolis, MN.
**NBRP - National Bioresource Project for C. elegans, Tokyo Women’s Medical University School of Medicine, Japan.
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Table 2-S2. Oligos, Probes and Peptides used in this study. 
 
Table S2
ACGCTCGTGATGAGTTCAAG eft-2 qPCR forward
ATTTGGTCCAGTTCCGTCTG eft-2 qPCR reverse
GGTTCCAAATGCCACAAGAG lin-41 qPCR forward
AGGTCCAACTGCCAAATCAG lin-41 qPCR reverse
GATCCTCCGATGAACGAAAA daf-12 qPCR forward
CTCTTCGGCTTCACCAGAAC daf-12 qPCR reverse
CTCACTGAGACTACATCAGC firefly luciferase qPCR forward
TCCAGATCCACAACCTTCGC firefly luciferase qPCR reverse
TCAATTCGTTCCAAAACTCTAcG kin-10 qPCR forward
GTATTTCCGCCGCTGTTTCC kin-10 qPCR reverse
CTTCCAGGGAATTCTCGACCG cgh-1 qPCR forward
GCATGAACGAAGTGACGGTG cgh-1 qPCR reverse
TACATACTTCTTTACATTCCA miR-1
AACTATACAACCTACTACCTCA let-7
TCGCATCTACTGAGCCTACCTCA miR-48
TGCCGTACTGAACGATCTCA miR-58
QAGSLAPGVPIGNTSVSI(C) ALG-1
WGDPPLSDVQYPLQPHASF(C) AIN-1
(C)IEPIPKTVDPKLYVADQQLVDA CGH-1
MPPIPSRARVYAEVNPSRP(C) KIN-3
(C)AEGLALADHRREPRLQTLVNDY TSN-1
(C)GRNNTPFNASDDAFPALGAK VIG-1
MSGAEQQQIVPANNGDENWK site 1
QEASIGVALTGQDILARAKN site 2
LGVAINLITYEDRHTLRRIE site 3
RRIEQELRTRIEPIPKTVDP site 4
DNA Oligos
Antigenic Peptides
Starfire Probes 
CGH-1 GST Peptides
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Table 2-S3. Quantification of mature miRNAs. 
 
 
  
Table S3
miRNA vector kin-3 RNAi kin-10 RNAi
let-7 49,795.02 63,690.70 38,749.08
lin-58 268,688.59 271,742.44 270,386.06
lsy-6 0.61 0.24 0.85
mir-1 73,658.84 81,012.21 65,989.66
mir-1018 2.47 1.15 2.20
mir-1019 0.11 0.10 0.39
mir-1020 1.59 1.60 1.31
mir-1022 659.16 595.35 637.46
mir-1817 0.15 0.04 0.00
mir-1819 40.48 33.35 25.28
mir-1820 2.01 1.15 1.62
mir-1821 0.76 0.45 0.85
mir-1822 0.19 0.52 0.31
mir-1823 0.19 0.07 0.08
mir-1824 1.14 1.56 0.97
mir-1828 0.00 0.00 0.00
mir-1829.2 110.01 69.58 77.61
mir-1830 0.80 1.87 0.70
mir-1834 1.18 1.01 0.89
mir-2207 0.15 0.10 0.00
mir-2208.2 0.53 0.52 0.35
mir-2209.1 7.28 5.52 5.10
mir-2209.2 0.00 0.04 0.00
mir-2209.3 0.00 0.04 0.04
mir-2210 0.30 0.45 0.54
mir-2211 1.02 0.97 0.73
mir-2212 4.17 4.51 4.06
mir-2213 0.30 0.17 0.16
mir-2216 0.53 0.45 0.54
mir-2219 0.38 0.24 0.27
mir-2220 0.11 0.07 0.16
mir-228 10,911.28 8,888.95 9,202.60
mir-229 76.02 79.40 61.76
mir-230 883.70 573.97 882.77
mir-231 26.48 26.13 27.79
mir-232 4.93 6.94 6.11
mir-235 364.48 282.23 112.09
mir-237 94.42 103.31 79.43
mir-238 138.54 127.08 89.90
Normalized reads per million mapped reads
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mir-239.1 69.04 77.39 63.66
mir-239.2 109.52 63.44 38.69
mir-240 23.60 24.50 7.69
mir-241 10,173.44 10,289.80 9,281.79
mir-242 3.98 3.75 4.10
mir-243 8.31 10.27 10.78
mir-244 11.27 16.24 7.89
mir-245 3.11 2.46 2.28
mir-246 11.19 12.67 7.11
mir-247 1.90 0.97 1.86
mir-248 66.31 70.90 67.72
mir-249 0.30 0.28 0.46
mir-251 15.74 10.03 7.34
mir-252 299.08 298.78 211.61
mir-259 2.01 1.98 1.51
mir-260 0.38 0.21 0.23
mir-262 0.19 0.04 0.19
mir-265 0.11 0.00 0.00
mir-34 2,436.66 2,547.27 2,759.50
mir-35 239.22 242.67 190.16
mir-355 0.04 0.07 0.04
mir-356 0.15 0.04 0.12
mir-359 0.27 0.42 0.08
mir-36 42.75 47.82 43.29
mir-360 0.04 0.04 0.00
mir-37 719.97 787.98 659.22
mir-392 0.27 0.28 0.12
mir-40 79.78 105.43 82.94
mir-42 26.86 36.13 28.49
mir-43 5.01 4.23 4.95
mir-46 0.30 0.38 0.35
mir-47 9.29 13.92 6.88
mir-49 83.27 93.45 89.78
mir-50 625.78 622.21 574.38
mir-53 2.88 5.73 3.05
mir-54 991.97 721.77 545.62
mir-55 1,396.36 1,089.57 989.21
mir-56 853.47 782.67 644.99
mir-57 1,711.18 1,010.31 1,832.21
mir-59 20.18 28.77 21.03
mir-60 27.39 30.85 32.00
mir-61 351.43 244.96 252.97
mir-63 263.12 321.93 286.94
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mir-64 248.67 287.78 261.39
mir-65 149.47 242.78 192.17
mir-72 24,746.19 19,737.11 22,788.62
mir-73 16,717.42 14,438.91 14,659.61
mir-74 16.20 26.76 13.88
mir-75 532.38 711.95 560.20
mir-76 5.39 3.68 4.41
mir-77 13.88 26.24 16.50
mir-78 0.00 0.00 0.00
mir-784 1.67 2.71 1.01
mir-785 21.70 19.54 14.15
mir-786 7.28 9.27 4.95
mir-787 22.53 20.96 18.51
mir-788 64.83 46.64 35.17
mir-79 17.64 58.06 52.80
mir-790 7.89 5.21 4.91
mir-791 16.27 12.46 12.06
mir-792 0.65 0.38 0.08
mir-793 18.17 14.05 12.87
mir-794 2.77 2.67 2.94
mir-795 540.50 398.03 498.20
mir-796 40.40 32.72 29.41
mir-797 3.64 2.60 4.48
mir-798 4.06 3.37 1.51
mir-800 0.08 0.28 0.19
mir-84 305.87 302.32 242.84
mir-85 88.54 78.25 41.12
mir-90 197.91 158.21 191.09
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Table 2-S4. Salient proteins and peptides identified in CGH-1::GFP mass 
spectrometry.  
Table S4
Protein Peptide Coverage Spectral Counts
KIN-3 32.5% 16
KIN-10 30.3% 6
NHL-2 4.5% 2
VIG-1 14.3% 3
AIN-1 0% 0
ALG-1 0% 0
TSN-1 0% 0
CGH-1 32.6% 16
Protein Peptide Coverage Spectral Count/Peptide Peptides
3 MSGAEQQQIVPANNGDENWK.A 
4 MSGAEQQQIVPANNGDENWK.A *
5  SGAEQQQIVPANNGDENWK.A
3   GAEQQQIVPANNGDENWK.A
11    AEQQQIVPANNGDENWK.A
7     EQQQIVPANNGDENWK.A
7      QQQIVPANNGDENWK.A
17         IVPANNGDENWK.A
15          VPANNGDENWK.A
S: phosphorylated amino acid                 
* phosphopeptide not identified in kin-3 RNAi sampletotal spectral count 72
 CGH-1::GFP Phospho-Mass spectrometry
Mass spectrometry of CGH-1::GFP complexes
4.4%CGH-1
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